Page last updated: 2024-08-24

gemcitabine and Carcinoma, Transitional Cell

gemcitabine has been researched along with Carcinoma, Transitional Cell in 351 studies

Research

Studies (351)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	9 (2.56)	18.2507
2000's	158 (45.01)	29.6817
2010's	136 (38.75)	24.3611
2020's	48 (13.68)	2.80

Authors

Authors	Studies
Ando, R; Banno, R; Etani, T; Hamamoto, S; Iida, K; Isobe, T; Kawai, N; Kubota, H; Nagai, T; Naiki, T; Naiki-Ito, A; Noda, Y; Nozaki, S; Shimizu, N; Sugiyama, Y; Tomiyama, N; Yasui, T	1
Anai, S; Aoki, K; Fujimoto, K; Gotoh, D; Hori, S; Ichikawa, K; Kiba, K; Maesaka, F; Matsumura, Y; Miyake, M; Mizobuchi, S; Morizawa, Y; Nakai, Y; Nishimura, N; Oda, Y; Ohmori, C; Shimizu, T; Tachibana, A; Tanaka, N; Tomizawa, M; Torimoto, K; Yoshikawa, T	1
Kiyozuka, K; Kohei, N; Suzuki, R	1
Bao, G; Chaohong, H; Shiming, Z; Tiejun, Y; Yin, H; Yongkang, M	1
Jeong, BC; Kim, CK; Kim, H; Kim, R; Kwon, GY; Park, SH; Park, W; Song, W; Sung, HH	1
Allory, Y; Chevreau, C; Culine, S; Fléchon, A; Gravis, G; Guillot, A; Harter, V; Joly, F; Laguerre, B; Mahammedi, H; Pfister, C; Soulié, M	1
Clark, PE; Meeks, JJ; Sexton, WJ	1
Hashimoto, K; Hinotsu, S; Hotta, H; Ito, N; Kato, R; Kobayashi, K; Kunishima, Y; Maehana, T; Masumori, N; Matsukawa, M; Miyamoto, S; Shindo, T; Tachiki, H; Taguchi, K; Takahashi, A; Tanaka, T	1
Aydin, AM; Cheriyan, SK; Gilbert, SM; Hajiran, A; Jain, R; Li, R; Peyton, CC; Poch, MA; Reich, R; Sexton, WJ; Spiess, PE; Yu, A; Zemp, L; Zhang, J	1
Adachi, T; Azuma, H; Egawa, S; Fukuokaya, W; Fukushima, T; Hashimoto, T; Inamoto, T; Iwatani, K; Kimura, T; Komura, K; Miki, J; Mori, K; Nakamori, K; Nakamura, K; Nishimura, K; Nishio, K; Ohno, Y; Shiroki, R; Takahara, K; Tsuduki, S; Uchimoto, T; Urabe, F; Yamamoto, S; Yanagisawa, T; Yano, Y; Yoshizawa, A	1
Bao, Y; Cai, M; Chen, M; Chen, Z; Fu, C; Guo, J; Hu, H; Huang, J; Huang, Z; Jiang, S; Li, C; Su, R; Wang, Z; Wei, Q; Xue, W; Yuan, Y; Zheng, B	1
Fantinel, E; Manduca, S; Merler, S; Milella, M; Pafumi, S; Zacchi, F; Zampiva, I; Zivi, A	1
Hong, J; Hong, JY; Jeong, BC; Kim, CK; Kim, H; Kwon, GY; Park, SH; Park, W; Pyo, H; Song, W; Sung, HH	1
Blaheta, RA; Chun, FK; Cinatl, J; Grein, T; Haferkamp, A; Khadir, SE; Makhatelashvili, N; Mann, J; Maxeiner, S; Rutz, J; Sonnenburg, M; Thomas, A; Tsaur, I; Xie, H	1
Ikeda, M; Iwamura, M; Katsumata, H; Koguchi, D; Matsumoto, K; Nakamura, M; Sato, Y; Shimizu, Y; Shiono, Y	1
Akiyama, Y; Fukuhara, H; Kawai, T; Kinjo, M; Kishitani, K; Kume, H; Masuda, K; Miyakawa, J; Nakagawa, T; Nakamura, Y; Sato, Y; Sugimoto, K; Taguchi, S; Tambo, M; Yamada, D; Yamada, Y	1
Fujii, T; Fujimoto, K; Gotoh, D; Hori, S; Iida, K; Miyake, M; Miyamoto, T; Morizawa, Y; Nakai, Y; Nishimura, N; Oda, Y; Ohnishi, K; Ohnishi, S; Owari, T; Shimizu, T; Tanaka, N; Torimoto, K	1
Al-Ahmadie, HA; Alvim, RG; Apolo, AB; Baccala, AA; Bajorin, DF; Benfante, NE; Bochner, BH; Cha, EK; Coleman, JA; Dalbagni, G; Donahue, TF; Donat, SM; Ghafoor, S; Hakimi, AA; Herr, HW; Iyer, G; Kamradt, JM; Kim, K; Lash, BW; Meraney, AM; Muina, AF; Nair, SG; Palyca, P; Pietzak, EJ; Rizvi, MA; Rosenberg, JE; Shichman, SJ; Sjoberg, DD; Swanson, SK; Teo, MY; Vargas, HA; Wong, NC; Yip, W	1
Baba, Y; Hasegawa, M; Hishiki, T; Kikuchi, E; Kosaka, T; Matsumoto, K; Mikami, S; Miyajima, A; Mizuno, R; Naito, Y; Oya, M; Saya, H; Shigeta, K	1
Abe, T; Hotta, K; Iwami, D; Kikuchi, H; Matsumoto, R; Osawa, T; Shinohara, N; Tanabe, T	1
Chang, IH; Choi, SY; Ha, MS; Kim, H; Kim, M; Kim, TH; Kim, Y; Kyoung, DS; Lee, KE; Lee, YS; Myung, SC; Nguyen, TT; Tae, JH; Woo, HK	1
Horenblas, S; Los, M; Reesink, DJ; van de Garde, EMW; van der Nat, PB; van Melick, HHE	1
Albers, P; Bannowsky, A; Becht, E; Fischer, C; Heinzelbecker, J; Hofmann, R; Kamradt, J; Kuehn, M; Langbein, S; Lehmann, J; Müller, M; Retz, M; Spieler, N; Steiner, G; Stoeckle, M; Volkmer, B; von Rundstedt, F; Wagenpfeil, G; Weber, HM; Wellek, S	1
Alonzi, R; Birtle, A; Cheung, KC; Choudhury, A; Foroudi, F; Gribble, H; Griffin, C; Hafeez, S; Hall, E; Henry, A; Hilman, S; Hindson, B; Huddart, R; Lewis, R; McLaren, DB; McNair, H; Muthukumar, D; Nikapota, A; Olorunfemi, A; Omar, A; Parikh, O; Philipps, L; Rimmer, Y; Syndikus, I; Tolentino, A; Varughese, M; Vassallo-Bonner, C; Webster, A	1
Mochida, J; Obinata, D; Takada, S; Takahashi, S; Uchida, H; Yamaguchi, K; Yoshizawa, T	1
Alqaisi, H; Chan, CT; Côté, G; Jiang, DM; Kandel, C; Kitchlu, A; Pelletier, K; Sridhar, SS; Wald, R	1
Small, EJ	1
Audenet, F; Bendjeddou, L; Calleris, G; Chevallier, T; Houédé, N; Masson-Lecomte, A; Neuzillet, Y; Rouprêt, M; Seisen, T; Thibault, C; Xylinas, E	1
Bamias, A; Bedke, J; Beuzeboc, P; Burotto, M; Chatta, G; Filian, J; Galsky, MD; He, Z; Ku, JH; Nasroulah, F; Necchi, A; Oldenburg, J; Patel, MY; Powles, T; Purcea, D; Sade, JP; Schenker, M; Sonpavde, G; Tomita, Y; Ürün, Y; Valderrama, BP; van der Heijden, MS; Wang, L; Ye, D	1
Batteson, R; de Wit, R; Grivas, P; Keefe, S; Li, H; Meng, Y; Patterson, K; Pellissier, J; Prabhu, V; Xu, R; Zarabi, N; Zhong, Y	1
Bracco, OL; Frenkl, T; Freshwater, T; Keefe, S; Li, H; Li, M; Perini, R; Valiathan, C	1
Hikita, K; Honda, M; Iwamoto, H; Kimura, Y; Morizane, S; Nishikawa, R; Takenaka, A; Teraoka, S; Yumioka, T	1
Chen, M; Fu, G; Guan, Y; Guo, Z; Jiang, H; Jiang, X; Liang, J; Lu, T; Niu, X; Sun, R; Sun, S; Sun, X; Tang, J; Wang, H; Wang, X; Wu, K; Wu, X; Yang, C; Zheng, S; Zhong, B	1
Akita, H; Ando, R; Chaya, R; Etani, T; Iida, K; Kobayashi, D; Moritoki, Y; Nagai, T; Naiki, T; Nozaki, S; Okamura, T; Sugiyama, Y; Yanase, T; Yasui, T	1
Sridhar, SS	1
Abate-Shen, CT; Anderson, CB; DeCastro, GJ; Drake, CG; Holder, D; James, B; Kates, MM; Lee, SM; McKiernan, JM; Pak, JS; Sui, W; Virk, RK	1
Montgomery, RB; Ruplin, AT; Spengler, AMZ; Wright, JL	1
Peard, L; Saltzman, AF; Stark, T; Ziada, A	1
Birtle, A; Casbard, A; Chester, J; Crabb, S; Elliott, T; Evans, L; Griffiths, G; Huang, C; Huddart, R; Jagdev, S; Jones, R; Lester, J; Madden, TA	1
Donnell, R; Hong, T; Hu, Y; Pattarawat, P; Tsai, CL; Wallace, S; Wang, HR; Wang, J; Wang, TH	1
Cho, DH; Kim, KM; Lee, DH; Lee, NR; Yim, CY	1
Alsyouf, M; Groegler, J; Hu, B; Pierorazio, P	1
Fukami, N; Fukaya, K; Ichino, M; Kusaka, M; Nukaya, T; Sasaki, H; Shiroki, R; Sumitomo, M; Takahara, K; Takenaka, M; Zennami, K	1
Cao, T; Fan, D; Gao, X; Gao, Z; Guo, F; Luo, X; Xing, Q; Yang, F; Zhang, L; Zhang, S	1
Barocas, DA; Bivalacqua, TJ; Black, PC; Cookson, MS; D'Andrea, D; Dall'Era, MA; Daneshmand, S; Dinney, CP; Holzbeierlein, JM; Kassouf, W; Lotan, Y; Matin, S; McGrath, JS; Morgan, TM; North, S; Petros, FG; Shariat, SF; Spiess, PE; Sridhar, SS; Stephenson, AJ; Thorpe, AC; van Rhijn, BW; Wright, JL; Zargar, H	1
Hussain, SA; Riaz, IB	1
Huang, CP; Shyr, CR; Wu, CC	1
Adachi, H; Hotta, H; Ito, N; Kato, R; Kunishima, Y; Maehana, T; Masumori, N; Matsukawa, M; Shindo, T; Tachiki, H; Taguchi, K; Takahashi, A; Tanaka, T	1
Farrow, JM; Gryzinski, GM; Kern, SQ; Sundaram, CP	1
Fujimoto, N; Harada, M; Inatomi, H; Minato, A; Onishi, R; Terado, M; Tomisaki, I	1
Yuasa, T	1
Cui, Y; Dreicer, R; Emamekhoo, H; Frankel, PH; Hoimes, C; Kim, WY; Lara, PN; Lyou, Y; Michaelson, D; Milowsky, M; Mortazavi, A; Newman, E; Pal, SK; Parikh, M; Parikh, R; Srinivas, S; Teply, B; Vaishampayan, U; Weng, P; Zhang, T	1
Chen, CS; Cheng, CL; Chiu, KY; Ho, HC; Hung, SC; Li, JR; Ou, YC; Wang, SS; Yang, CK	1
Ando, R; Hotta, Y; Kimura, K; Kondo, M; Yasui, T	1
Böhm, R; Grünberger, B; Kraischits, N; Kudlacek, S; Kunit, T; Lamche, M; Loidl, W; Meran, JG; Niedersüss-Beke, D; Puntus, T; Schramek, P	1
An, X; Deng, YF; Jiang, WQ; Li, LR; Shao, C; Shi, YX; Sun, P; Thomas, R; Xue, C; Yang, W	1
da Silva, GN; Filoni, LT; Salvadori, DMF; Salvadori, MC	1
Fujita, N; Hamano, I; Hashimoto, Y; Hatakeyama, S; Hosogoe, S; Iwamura, H; Koie, T; Kusaka, A; Ohyama, C; Tobisawa, Y; Yamamoto, H; Yoneyama, T	1
Chang, JW; Chang, YH; Chuang, CK; Juan, YH; Liao, TY; Liaw, CC	1
Barone, C; Bassi, P; Cassano, A; Marandino, L; Monterisi, S; Nazzicone, G; Orlandi, A; Pierconti, F; Racioppi, M; Rossi, E; Schinzari, G	1
Abdallah, A; Baumann, BC; Christodouleas, JP; Hwang, WT; Khaled, HM; Smith, A; William, H; Zaghloul, MS	1
Akers, N; Albany, C; Bhardwaj, N; Chen, R; Domingo-Domenech, J; Donovan, MJ; Fleming, MT; Galsky, MD; Gnjatic, S; Hahn, NM; Hauke, RJ; Kim-Schulze, S; Losic, B; Oh, WK; Pal, SK; Patel, VG; Schadt, EE; Sfakianos, JP; Sonpavde, G; Starodub, A; Twardowski, P; Uzilov, AV; Wang, H; Yu, M; Zhao, Q	1
Bivalacqua, TJ; Gupta, M; Hahn, NM; Johnson, MH; Kates, M; Liao, RS; McConkey, D; Patel, HD; Pierorazio, PM; Schwen, ZR	1
Bivalacqua, TJ; Black, PC; Daneshmand, S; Kassouf, W; Shah, JB; Spiess, PE; van Rhijn, BW; Zargar, H	1
Bell-McGuinn, K; Cristea, M; Fleming, GF; Gray, HJ; Luo, Y; Martin, LP; McKee, MD; Munasinghe, W; Sullivan, D; Xiong, H	1
Kwon, WA; Lee, JW; Oh, TH; Park, SC; Seo, IY	1
Martínez-Piñeiro, L; Rios González, E	1
Balasubramanian, A; Davis, JW; Dinney, CP; Kamat, AM; Karam, JA; Matin, SF; Metcalfe, MJ; Navai, N; Papadopoulos, J; Wagenheim, G; Wood, CG; Xiao, L	1
Aujla, PK; Beckett, LA; Lara, PN; Li, Y; Pan, CX; Parikh, M; Robles, DA	1
Deshpande, H; Donadio, A; Hurwitz, ME; Kelly, WK; Markowski, P; Mehnert, JM; Mortazavi, A; Patel, J; Petrylak, DP; Stein, MN; Yao, X	1
Kim, HS; Seo, HK	1
Apolo, AB; Chowdhury, S; Galsky, MD; Hahn, NM; Merseburger, AS; Milowsky, MI; Petrylak, D; Powles, T; Quinn, DI; Rosenberg, JE; Siefker-Radtke, A; Sonpavde, G; Sternberg, CN	1
Ahmadi, N; Amini, E; Bazargani, ST; Cai, J; Clifford, TG; Daneshmand, S; Djaladat, H; Hugen, CM; Miranda, G; Sherrod, AE	1
Choi, HY; Jeon, HG; Jeon, SS; Jeong, JY; Lee, HM; Seo, SI; Song, W; Sung, HH	1
Chi, KN; Eigl, BJ; Forbes, C; Parimi, S; Tsang, ES	1
Huang, CH; Huang, CN; Lee, MH; Li, CC; Li, WM; Tsai, CC; Wu, WJ; Yeh, HC	1
Chun, F; Gontero, P; Gurioli, A; Kluth, LA; Lucca, I; Marson, F; Martorana, G; Mehnert, A; Oderda, M; Pappagallo, G; Rink, M; Sanguedolce, F; Schiavina, R; Schmid, M; Shariat, SF; Sogni, F	1
Abacioglu, U; Alsan Cetin, I; Atasoy, BM; Dane, F; Ibrahimov, R; Ozgen, Z; Turhal, NS; Turkeri, L; Ucuncu Kefeli, A	1
Gschwend, JE; Horn, T; Kübler, HR; Ladwein, B; Maurer, T; Redlin, J; Retz, M; Seitz, AK	1
Khunnarong, J; Manusirivithaya, S; Pataradool, K; Pitakkarnkul, S; Prutthiphongsit, W; Srijaipracharoen, S; Tangjitgamol, S; Thavaramara, T	1
Bajorin, DF; Bochner, BH; Dalbagni, G; Kent, M; Kim, PH; Sfakianos, JP; Zhao, P	1
Cass, CE; El-Gehani, F; Ghosh, S; Lai, R; Mackey, JR; North, S; Santos, C	1
Eberhart, C; Goldberg, MF; Hsu, AW; Montaner, S; Sodhi, A	1
Bellmunt, J; Blais, N; Castellano, D; Cerbone, L; Le-Guennec, S; Machiels, JP; Peters, F; Risse, ML; Skoneczna, IA; Sternberg, CN; Theodore, C; Voog, E	1
Alfred Witjes, J; Arentsen, HC; Falke, J; Høgset, A; Oosterwijk, E	1
Camargo, EA; da Silva, GN; Gobette, CP; Marcondes, JP; Salvadori, DM	1
Cheng, CC; Chiu, TH; Huang, YT; Lai, PC; Lin, TC	1
Cury, FL; Duclos, M; Faria, SL; Kassouf, W; Souhami, L; Sturgeon, J; Turgeon, GA	1
Chi, Y; Song, Y; Wang, J; Yang, L; Zhou, A	1
Agarwal, N; Al-Hawary, M; Daignault, S; Dawsey, S; Day, KC; Day, ML; Eisenberger, MA; Grivas, PD; Hussain, M; Levine, EG; MacVicar, GR; Puzanov, I; Quinn, DI; Siefker-Radtke, AO; Smith, DC; Srinivas, S; Twardowski, P; Vaishampayan, UN; Yu, EY	1
Badran, A; Enein, HA; Ghoneim, M; Kalawee, ME; Khaled, HM; Mahran, TZ; Manie, M; Mansur, O; Megeed, HA; Ramadan, SM; Saber, RA; Shafik, HE; Sherbini, ME; Zabhloul, MS	1
Chiu, CC; Hour, TC; Hsu, SH; Hsu, WC; Hu, HT; Huang, AM; Kao, YT; Lin, CS; Lu, CY; Pu, YS	1
Bachner, M; Cerveny, M; De Santis, M; Dittrich, C; Kametriser, G; Königsberg, R; Schratter-Sehn, A; Sedlmayer, F; Steininger, T	1
Beardo Villar, P; Gamaza Martínez, R; Gavira Moreno, R	1
Arai, Y; Ito, A; Kaiho, Y; Mitsuzuka, K; Nakagawa, H; Namiki, S; Saito, H; Sato, K; Yamada, S; Yamashita, S	1
Allory, Y; Bouquot, M; Comperat, E; de la Taille, A; Masson-Lecomte, A; Rouprêt, M; Sibony, M; Xylinas, E; Zerbib, M	1
Banu, E; Bay, JO; Beuzeboc, P; Culine, S; Deplanque, G; Elaidi, R; Goldwasser, F; Gravis, G; Machiels, JP; Muracciole, X; Nguyen, T; Oudard, S; Pichon, MF; Priou, F; Radvanyi, F; Ravaud, A; Teghom, C; Théodore, C; Vannetzel, JM; Vano, Y; Vieillefond, A; Voog, E	1
Chovanec, M; Mardiak, J; Mego, M; Obertova, J; Palacka, P; Sycova-Mila, Z	1
Chau, C; Crabb, SJ; Geldart, T; Wheater, M	1
Ichimaru, N; Kojima, Y; Nonomura, N; Okumi, M; Takahara, S; Takahi, Y	1
Li, Y; Shang, YM; Yang, Y; Zheng, H	1
Agarwal, N; Bellmunt, J; Berthold, D; Chowdhury, S; Crabb, SJ; Galsky, MD; Harshman, LC; Hussain, SA; Ladoire, S; Milowsky, MI; Moshier, EL; Necchi, A; Pal, SK; Powles, T; Recine, F; Rosenberg, JE; Theodore, C; Vaishampayan, UN; Wong, YN; Yu, EY	1
Ali-El-Dein, B; Babjuk, M; Burger, M; Chang, SS; Clayman, RH; Daneshmand, S; Efstathiou, JA; Fritsche, HM; Gakis, G; Galland, S; Hrbacek, J; Keegan, KA; Mischinger, J; Morgan, TM; Olugbade, K; Rink, M; Schubert, T; Stenzl, A; Thalmann, GN; Todenhöfer, T; Zaid, HB	1
Hashimoto, Y; Hatakeyama, S; Imai, A; Koie, T; Ohyama, C; Yoneyama, T	1
Ichioka, D; Inoue, T; Kageyama, S; Kikuchi, E; Kinoshita, H; Matsui, Y; Mitsuzuka, K; Miyazaki, J; Nishiyama, H; Nomoto, T; Shiraishi, Y; Sugimoto, M; Wakeda, H	1
Miller, K; Morant, R; Stenzl, A; Wirth, M; Zuna, I	1
Horita, H; Hotta, H; Kato, R; Kitamura, H; Kunishima, Y; Masumori, N; Takahashi, A; Takei, F	1
Bergman, AM; Bex, A; Horenblas, S; Kerst, JM; Meijer, RP; Mertens, LS; van de Putte, EE; van der Heijden, MS; van der Poel, HG; van Rhijn, BW	1
Arriaga, Y; Courtney, K; Krabbe, LM; Lotan, Y; Margulis, V; Raj, GV; Sagalowsky, AI; Westerman, ME	1
Asai, A; Matsuo, T; Mitsunari, K; Miyata, Y; Ohba, K; Sakai, H	1
Bokemeyer, C; Oechsle, K; Oing, C; Rink, M; Seidel, C; von Amsberg, G	1
Feng, YH; Huang, KH; Li, CF; Lin, KL; Shen, KH; Tzeng, WS	1
Chalasani, V; Gunaratne, DA; Krieger, LE; Maclean, F; Vaux, KJ	1
Dolan, DE; Gupta, S; Jan, AS; Lombardi, K	1
Jeong, CW; Kim, HH; Kim, HS; Ku, JH; Kwak, C	1
Kitaoka, H; Kubo, T; Nakashima, Y; Syuin, T; Tanioka, K; Yamasaki, I; Yamasaki, N	1
Apolo, AB; Bajorin, DF; Furberg, HF; Ostrovnaya, I; Regazzi, AM; Rosenberg, JE; Tully, CM; Zabor, EC	1
Hagiwara, M; Hanai, K; Ichioka, D; Inoue, T; Kageyama, S; Kikuchi, E; Kinoshita, H; Matsui, Y; Mitsuzuka, K; Miyazaki, J; Nishiyama, H; Sugimoto, M; Wakeda, H; Yamamoto, S; Yuge, K	1
Jha, V; Ojha, R; Singh, SK	1
Albiges, L; Bellmunt, J; Culine, S; De Santis, M; Flechon, A; Lin, CC; Loidl, WC; Lucas, C; Mourey, L; Necchi, A; Retz, MM; Senkus-Konefka, E; Su, WC; Vaissière, N; Wiechno, PJ	1
Dobelbower, MC; Dreicer, R; George, A; Heney, NM; Kaufman, DS; Mitin, T; Sandler, HM; Shipley, WU; Souhami, L; Uzzo, RG; Wallace, HJ; Zietman, AL	1
Campbell, MT; Carolla, RL; Harris, DR; Munsell, MF; Pagliaro, LC; Siefker-Radtke, AO	1
Bolenz, C; Budjan, J; Erben, P; Gaiser, T; Michel, MS; von Hardenberg, J; Wezel, F	1
Ezaki, T; Kikuchi, E; Matsumoto, K; Mizuno, R; Morita, S; Oya, M; Shinoda, K	1
Hattori, Y; Inayama, Y; Ishida, H; Kawahara, T; Kondo, T; Kumano, Y; Maeda, Y; Miyoshi, Y; Mochizuki, T; Ohtaka, M; Teranishi, J; Uemura, H; Yao, M; Yumura, Y	1
Albany, C; Bihrle, R; Cary, KC; Cheng, L; Cho, JS; Foster, RS; Gellhaus, PT; Hahn, NM; Kaimakliotis, HZ; Koch, MO; Masterson, TA; Monn, MF; Pedrosa, JA	1
Bellmunt, J; Galsky, MD; Giannatempo, P; Grivas, P; Necchi, A; Pond, GR; Raggi, D; Sonpavde, G; Vogelzang, NJ	1
Apolo, AB; De Santis, M; Galsky, MD; Leibovich, BC; Milowsky, MI; Pham, MN; Pisters, LL; Siefker-Radtke, AO; Sonpavde, G; Steinberg, GD; Sternberg, CN; Tagawa, ST; Weizer, AZ; Woods, ME	1
Fujie, K; Inoue, T; Ishitsuka, R; Kageyama, S; Keino, N; Kikuchi, E; Kinoshita, H; Matsui, Y; Mitsuzuka, K; Miyazaki, J; Nishiyama, H; Nomoto, T; Ogawa, O; Shiraishi, Y; Sugimoto, M; Wakeda, H	1
Gakis, G	1
Domingo-Domenech, J; Ferket, BS; Galsky, MD; Sfakianos, JP	1
Feuz, L; Gee, ME; Krajewski, KC; Kurtzhalts, K	1
Msaouel, P; Tu, SM; Zhang, M	1
Cho, MH; Chung, J; Joung, JY; Kim, SH; Lee, KH; Park, WS; Seo, HK	1
Cabezuelo, B; de la Vara Inesta, L; Illescas, ML; Jimeno García, L; López Rubio, ME; Lucas Guillén, E; Martinez Díaz, M; Mateo Bosch, E; Morales Albuja, ME; Rodado Martínez, R	1
Plimack, ER; Ramamurthy, C; Zibelman, M	1
Costello, JC; Kanigel Winner, KR	1
Fukushi, K; Hashimoto, Y; Hatakeyama, S; Imai, A; Koie, T; Matsumoto, T; Narita, T; Ohyama, C; Soma, O; Tobisawa, Y; Yamamoto, H; Yoneyama, T	1
Agarwal, N; Alva, A; Bamias, A; Bellmunt, J; Casey, MF; Crabb, SJ; De Giorgi, U; Galsky, MD; Harshman, LC; Ladoire, S; Necchi, A; Niegisch, G; Pal, SK; Powles, T; Ramos, JD; Recine, F; Rosenberg, JE; Vaishampayan, UN; Wong, YN; Yu, EY	1
Cinatl, J; Hoffmann, MJ; Isono, M; Michaelis, M; Niegisch, G; Pinkerneil, M; Sato, A; Schulz, WA	1
Del-Barrio-Díaz-Aldagalan, A; Garrido-Abad, P; López-Elzaurdia, C; Méndez-Rubio, S; Platas-Sancho, A; Rodríguez-Cabello, MA; Saenz-Medina, J; Sanz-Miguelañez, JL	1
Alsdorf, WH; Avilov, SA; Bokemeyer, C; Dyshlovoy, SA; Hauschild, J; Honecker, F; Kalinin, VI; Madanchi, R; Otte, K; Schumacher, U; Silchenko, AS; Stonik, VA; von Amsberg, G	1
Alexandre, J; Blanchet, B; Goldwasser, F; Henon, C; Huillard, O; Preta, LH	1
Fukushi, K; Hashimoto, Y; Hatakeyama, S; Koie, T; Narita, T; Ohyama, C; Tobisawa, Y; Yamamoto, H; Yoneyama, T	1
Cheng, T	1
Bajorin, DF; Bochner, BH; Boyle, MG; Dalbagni, G; Dash, A; Donat, SM; Herr, HW; Milowsky, MI; Pettus, JA; Russo, P	1
Beekman, K; Dunn, RL; Hussain, M; Lee, CT; Mackler, NJ; Montie, JE; Petrylak, DP; Quinn, DI; Sanda, M; Smith, DC; Vaishampayan, U; Wood, D	1
Habuchi, T; Horikawa, Y; Inoue, T; Kumazawa, T; Narita, S; Obara, T; Saito, M; Satoh, S; Tsuchiya, N; Yuasa, T	1
Lee, CT; Montie, JE; Oh, KS; Sandler, HM; Smith, DC; Soto, DE	1
Dorff, TB; Miranda, G; Quinn, DI; Skinner, DG; Stein, JP; Tsao-Wei, D	1
Lebret, T; Méjean, A	1
Kanai, K; Kikuchi, E; Miyajima, A; Nakagawa, K; Nakashima, J; Ohigashi, T; Oya, M	1
Campbell, SC; Dreicer, R; Fergany, AF; Garcia, JA; Gong, MC; Hansel, DE; Jones, JS; Klein, EA; Stephenson, AJ; Weight, CJ	1
Bajorin, D; Halabi, S; Philips, GK; Sanford, BL; Small, EJ	2
Han, H; Li, YH; Liu, ZW; Qin, ZK; Wu, PH; Xiong, YH; Yu, SL; Zhou, FJ	1
Crawford, ED; deVere White, RW; Goldman, B; Hussain, MH; Lara, PN; Smith, DC; Tangen, CM; Wood, DP	1
Bartel, P; Ecke, TH; Gerullis, H; Koch, S; Ruttloff, J	1
Jian, W; Lerner, SP; Levitt, JM; Sonpavde, G; Yamashita, H	1
Böhle, A; Büttner, H; Frei, C; Helsberg, K; Knispel, HH; Kühn, M; Leyh, H; Lübben, B; Pottek, T; Soldatenkova, V; Stoffregen, C; Tschada, R; von Pokrzywnitzki, W; Wagner, W; Zorlu, F	1
Bajorin, DF; Iasonos, A; Maluf, FC; Milowsky, MI; Mironov, S; Nanus, DM; Regazzi, A; Riches, J; Shi, W	1
Lee, HJ; Lim, JS; Yang, YJ	1
Bartel, P; Ecke, TD; Gerullis, H; Koch, S; Ruttloff, J	1
Bellmunt, J; De Santis, M; de Wit, R; Kerst, JM; Leahy, M; Maroto, P; Marreaud, S; Mead, G; Skoneczna, I; Sylvester, R	1
Abbruzzese, A; Addeo, R; Bellini, S; Caraglia, M; Cennamo, G; Del Prete, S; Faiola, V; Guarrasi, R; Lanna, M; Miragliuolo, A; Montella, L; Vincenzi, B	1
Hudson, E; Lester, JF	1
Conrad, S; Heer-Sonderhoff, A; Schmorl, P; Vosshenrich, R	1
Cho, JS; Cho, KS; Chung, BH; Doo, SH; Hong, SJ; Kim, CI; Kim, SJ; Song, KH; Song, YS; Yang, WJ	1
Albers, P; Fechner, G; Fimmers, R; Heidenreich, A; Heimbach, D; Lehmann, J; Niegisch, G; Park, SI; Siener, R; Steiner, U	1
Ito, T; Kawashima, H; Nakatani, T; Omachi, T; Tamada, S	1
Aoki, K; Azuma, K; Fukumoto, T; Kikugawa, T; Miura, N; Nishida, T; Sasaki, T; Shimamoto, K; Tanji, N; Yanagihara, Y; Yokoyama, M	1
Caffo, O; Fellin, G; Galligioni, E; Graffer, U; Mussari, S; Tomio, L	1
Ayuso, D; Becht, C; Culine, S; Huguet, H; Iborra, F; Pouessel, D; Rebillard, X	1
Fujii, Y; Kawakami, S; Kihara, K; Koga, F; Masuda, H; Saito, K; Tatokoro, M; Yasuda, Y; Yokoyama, M	1
Bottomley, I; Choudhury, A; Clarke, NW; Cowan, RA; Elliott, PA; Kiltie, AE; Livsey, JE; Logue, JP; Lyons, J; McCaul, D; Ramani, V; Sangar, V; Swindell, R; Symonds, P; Wise, M; Wylie, JP	1
Chao, SY; Chou, CH; Hour, TC; Hu, HT; Huang, AM; Kao, YT; Lin, PY; Liou, JY; Lu, CY; Pu, YS; Toh, S	1
Cleves, A; Mason, M; Shelley, M; Wilt, TJ	1
Jeglum, AK; Lindner, D; Marconato, L; Nelson, V; Suslak-Brown, L; Zini, E	1
Mak, AL; Moibi, JA; Moore, RB; Sun, B	1
Cleves, A; Mason, MD; Shelley, MD; Wilt, TJ	1
Rexer, H	2
Jensen, JB; Jensen, KM; Ulhøi, BP	1
Boccardo, F; Cognetti, F; Felici, A; Gallucci, M; Giannarelli, D; Massidda, B; Muto, G; Pollera, CF; Rubagotti, A; Ruggeri, EM	1
Borut, K; Lijana, ZK	1
Baba, S; Fujita, T; Ikeda, M; Iwamura, M; Matsumoto, K; Minamida, S; Satoh, T; Tabata, K	1
Culine, S; Demery, ME; Pouessel, D; Thézenas, S	1
Ahn, H; Ahn, JH; Ahn, S; Hong, JH; Kim, CS; Kwon, JH; Lee, JL; Lim, HY; Park, SH; Song, C	1
Badalato, GM; Benson, MC; Hruby, G; McKiernan, JM; Petrylak, DP; RoyChoudhury, A; Wosnitzer, MS; Yeshchina, O	1
Bellmunt, J; Boehle, A; Chevreau, C; Collette, S; Daugaard, G; De Santis, M; de Wit, R; Laufman, LR; Marreaud, S; Mead, GM; Paz-Ares, L; Raghavan, D; Skoneczna, I; Sylvester, R; von der Maase, H; Winquist, E	1
Arbea, L; Aristu, J; Gil-Bazo, I; Moreno-Jimenez, M; Perez-Gracia, JL; Rodríguez-Ruiz, ME; San Miguel, I	1
Fukui, I; Kitsukawa, S; Komai, Y; Kubo, Y; Okubo, Y; Saito, K; Urakami, S; Yamamoto, S; Yasuda, Y; Yonese, J	1
Arslan, M; Ceylan, Y; Degirmenci, T; Gunlusoy, B; Kara, C; Kozacıoğlu, Z; Vardar, E	1
Chew, DJ; de Brito Galvao, JF; Inpanbutr, N; Kisseberth, WC; Murahari, S; Sutayatram, S	1
Abotouk, N; Halim, A	1
Dinney, CP; Grossman, HB; Kamat, AM; Millikan, RE; Shen, Y; Siefker-Radtke, AO; Williams, DL	1
Alici, S; Berk, V; Camcı, C; Coskun, U; Degerli, H; Gumus, M; Kaya, AO; Kefeli, U; Oner, MK; Ozdemir, NY; Ozkan, M; Ozturk, C; Sevinc, A; Unal, OU; Yilmaz, AU	1
Cai, J; Daneshmand, S; Dorff, T; Dorin, R; Fairey, AS; Lieskovsky, G; Miranda, G; Quinn, D; Schuckman, A; Skinner, EC	1
Asmar, L; Galsky, MD; Gardner, TA; Hahn, NM; Hellerstedt, BA; Hutson, TE; Kocs, D; Lerner, SP; McKenney, SA; Melnyk, AM; O'Rourke, M; Powles, T; Rauch, M; Sonpavde, G; Vogelzang, NJ; Wang, Y; Yu, M	1
Açikalin, M; Başeskioglu, B; Can, C; Duman, BB; Kara, IO; Yildirim, M	1
Vogelzang, NJ	1
Cheon, J; Choi, IK; Kang, SG; Kang, SH; Kim, HS; Kim, JS; Kim, ST; Kim, YH; Ko, YH; Lee, SW; Oh, SC; Park, JH; Park, KH; Park, YJ; Seo, JH; Sung, DJ	1
Barlow, LJ; Benson, MC	1
Logothetis, C; Millikan, R	1
Asse, E; Kallwellis, G; Klebingat, KJ; Protzel, C; Zimmermann, U	1
Crawford, ED	1
Bajorin, D; Dalbagni, G; dePalma, D; Donat, MS; Herr, HW; Mazumdar, M; Rabbani, F; Russo, P; Sheinfeld, J; Sogani, P; Tong, W	1
Alvarez Castelo, L; Blanco Díez, A; Fernández Rosado, E; González Martín, M; Rodríguez Gómez, I; Sánchez Rodríguez Losada, J; Suárez Pascual, G	1
Albanell, J; Baselga, J; Bellmunt, J; Carles, J; Climent, MA; Cortés-Funes, H; de la Cruz, JJ; Díaz-Rubio, E; González-Larriba, JL; Guillem, V; Paz-Ares, L	1
Fukui, I; Ishii, N; Maezawa, T; Tsukamoto, T; Yonese, J	1
Albers, P; Lehmann, J; Lippert, C; Retz, M; Stöckle, M	1
Egorin, MJ; Eisenberger, MA; Haisfield-Wolf, ME; Laufer, M; Nativ, O; Ramalingam, S; Schoenberg, MP; Trueheart, IN; Zuhowski, EG	1
Akman, Y; Alper, M; Cam, K; Kavak, A	1
von der Maase, H	4
Albers, P; Blatter, J; Fechner, G; Haase, L; Ludwig, E; Mller, SC; Perabo, FG; Schmidt, DH; Schueller, H	1
Butzbach, D; Cairdella, M; Capanna, T; DiPaola, RS; Dvorzhinski, D; Eid, J; Goodin, S; Rubin, E; Shih, JW; Todd, MB; Toppmeyer, D	1
Alonso, L; Arrivi, A; Carles, J; Font, A; Garrido, P; Juan, O; Mellado, B; Nogué-Aliguer, M; Sáenz, A	1
Dreicer, R; George, CS; Manola, J; Roth, BJ; Schneider, DJ; Schwerkoske, JF; Wilding, G	1
Carini, M; Corvino, C; Lapini, A; Meliani, E; Serni, S	1
Bodrogi, I	1
Al-Mwalad, M; Albers, P; Becker, T; Brauers, A; Brkovic, D; Bub, P; Derigs, HG; Fassmann, C; Hamza, A; Hartlapp, J; Henss, H; Hertle, L; Jaeger, E; Jakse, G; Kälble, T; Kaldenbach, U; Knuth, A; Koser, M; Lehmann, J; Lippert, C; Loch, T; Melchior, H; Muschter, R; Otto, C; Piechota, HJ; Pomer, S; Potratz, C; Retz, M; Richter, AE; Roloff, J; Roth, S; Steiner, G; Stockamp, K; Stöckle, M; Tunn, U; Van Ahlen, H; Walz, P; Weinknecht, S; Weissbach, L; Winter, E; Wirth, M	1
Allen, HJ; Baker, C; Bosserman, LD; Chapman, Y; Figlin, RA; Gitlitz, BJ; Patel, R; Sanchez, JD; Shapiro, RM	1
Genet, D; Labourey, JL; Ly, K; Martin, J; Szelag, JC; Tubiana-Mathieu, N; Vénat-Bouvet, L	1
Ariad, S; Cohen, AD; Grunwald, M; Lazarev, I; Mermershtain, W	1
Gschwend, JE; Hautmann, RE; Simon, J; Volkmer, B	1
Bolner, A; Caffo, O; Fellin, G; Galligioni, E; Graffer, U; Luciani, L; Tomio, L; Valduga, F	1
Baltaci, S; Bedük, Y; Göğüş, C; Göğüş, O; Türkölmez, K	1
Dawson, NA; Edelman, MJ; Houston, J; Lara, PN; Lauder, I; Law, LY; Meyers, FJ	1
Ali, SA; Fareed, A; Mallick, JA; Siddiqui, N	1
Akar, S; Akkoc, N; Birlik, M; Kirkali, Z; Manisali, M; Onen, F; Ozer, E; Tuzel, E	1
Arai, Y; Hoshi, S; Itoh, A; Ohyama, C; Okada, Y; Ono, K; Saito, S; Satoh, M; Sohma, F; Takeda, A; Yamashita, S; Yamato, T	1
Arai, Y; Habuchi, T; Horikawa, Y; Hoshi, S; Inoue, T; Kato, T; Matsuura, S; Ohyama, C; Saito, S; Sato, K; Satoh, S; Togashi, H; Tsuchiya, N	1
Helke, C; Hoschke, B; May, M; Seehafer, M	1
Esper, P; Griffith, KA; Hayman, JA; Herman, JM; Kent, E; Montie, J; Sandler, HM; Smith, DC; Sullivan, MA	1
Carcas, A; Duque, B; Garcia-Ribas, I; Palou, J; Salvador, J; Segarra, J; Villavicencio, H	1
Bessis, D; Guilhou, JJ; Guillot, B; Legouffe, E	1
Geh, JI; Hussain, SA; James, ND; Palmer, DH; Peake, DR; Riley, P; Spooner, D; Stocken, DD	1
Casetta, G; Frea, B; Gontero, P; Maso, G; Pretti, G; Sogni, F; Tizzani, A; Zitella, A	1
Anagnostopoulos, A; Aravantinos, G; Athanasios Dimopoulos, M; Bafaloukos, D; Bamias, A; Deliveliotis, C; Efstathiou, E; Kalofonos, C; Linardou, H	1
deVere White, RW; Ellison, LM; Gandour-Edwards, R; Goldberg, Z; Karpman, E; Saffarian, A	1
Hara, I; Kamidono, S; Kawabata, G; Miyake, H; Muramaki, M	1
Freiha, F; Morgan, K; Srinivas, S	1
Aronson, M; Dalal, E; Laufer, M; Nativ, O; Sabo, E	1
Han, H; Li, YH; Liu, ZW; Qin, ZK; Wang, B; Wang, H; Yu, SL; Zhou, FJ	1
Dorreen, M; Iscoe, N; Jonker, D; Wilson, JJ; Winquist, E; Wong, R	1
Autorino, R; Bianco, AR; D'Armiento, M; De Placido, S; Di Lorenzo, G; Giordano, A; Giuliano, M	1
Comella, P; Crucitta, E; De Lena, M; Gebbia, V; Lorusso, V; Mancarella, S; Mangiameli, A; Manzione, L; Muci, D; Palmeri, S; Pezzella, G; Rosati, G; Silvestris, N; Sobrero, A	1
Allegro, R; Galuffo, A; Pavone, C; Pavone-MacAluso, M; Serretta, V	1
Clarke, NW; Cowan, RA; Logue, JP; Lyons, J; McBain, CA; Ramani, VA; Sangar, VK; Wylie, JP	1
Alexopoulos, A; Ardavanis, A; Kandylis, C; Lainakis, G; Rigatos, G; Tryfonopoulos, D	1
Ansari, R; Einhorn, LH; Fisch, MJ; Fox, E; Juliar, B; Li, J; Sweeney, CJ; Yiannoutsos, C	1
Fukui, I; Hanada, E; Ishikawa, Y; Nakagawa, K; Okubo, Y; Satoh, Y; Tadokoro, M; Tsukamoto, T; Yonese, J	1
Jansen, CF; Schalken, JA; van der Heijden, AG; Verhaegh, G; Witjes, JA	1
Artz, A; Ryan, C; Stadler, WM; Vogelzang, NJ; Zimmerman, T	1
Guardino, AE; Srinivas, S	1
Bearden, JD; Greco, FA; Hainsworth, JD; Litchy, S; Meluch, AA; Schnell, FM; Yost, K	1
Caponigro, F; Chollet, P; de Balincourt, C; Fiedler, W; Fumoleau, P; Geoffrois, L; Lacombe, D; Peters, GJ; Ravaud, A; Theodore, C; Vermorken, JB	1
Förster, Y; Fuessel, S; Kotzsch, M; Kraemer, K; Krause, S; Meye, A; Schmidt, U; Schwenzer, B; Wirth, MP	1
Arning, M; Dogliotti, L; Moore, MJ; Oliver, T; Ricci, S; Roberts, JT; Sengelov, L; von der Maase, H; Zimmermann, A	1
Böhle, A; Brocks, CP; Büttner, H	1
Beckman, E; Carringer, M; Gårdmark, T; Malmström, PU	1
Badger, J; Kang, S; Srinivas, S; Uzieblo, A	1
Montie, JE	1
Bartoletti, R; Cai, T; Gacci, M; Ghezzi, P; Giubilei, G; Nerozzi, S; Repetti, F; Santelli, G; Sisani, M; Viggiani, F	1
Campodonico, F; Maffezzini, M	1
Simpson, A	1
Crausaz, S; Metcalfe, S	1
Adamo, B; Adamo, V; Alafaci, E; Garipoli, C; Magno, C; Maisano, C; Rossello, R; Scandurra, G; Scimone, A; Spitaleri, G	1
Albers, P; Fechner, G; Kobalz, L; Reimann, M; Siener, R	1
Canil, C; Chi, KN; Moore, M; Murray, RN; Tinker, A; Winquist, E	1
Bartoletti, R; Cai, T; Carini, M; Gacci, M; Ghezzi, P; Nerozzi, S; Nesi, G; Pinzi, N; Repetti, F; Viggiani, F	1
Carvalho, FM; Carvalho, JP; Feher, O; Maluf, FC; Schütz, FA	1
Abdelatif, M; Bidault, F; Bouvet-Forteau, N; de Crevoisier, R; di Palma, M; Fizazi, K; Laplanche, A; Theodore, C; Wibault, P	1
Fukui, I; Ohkubo, Y; Tsukamoto, T; Yonese, J	1
Ash, R; Passaperuma, K; Rodrigues, G; Venkatesan, V; Winquist, E	1
Bajorin, D; Ben-Porat, L; Bochner, B; Dalbagni, G; Donat, MS; Herr, HW; Russo, P; Sheinfeld, J; Sogani, P	1
Albiol, S; Bellmunt, J; de Olano, AR; Maroto, P; Pujadas, J	1
Arning, M; Conte, PF; Dogliotti, L; Moore, MJ; Oliver, T; Roberts, JT; Sengeløv, L; von der Maase, H; Zimmermann, A	1
Chen, G; Geertsen, PF; Gough, J; Gravis, G; Joensuu, H; Kania, M; Lehmann, J; von der Maase, H	1
Lehmann, J; Retz, M; Schreier, U; Siemer, S; Stöckle, M; Zwergel, U	1
Hendricksen, K; Witjes, JA	1
Helke, C; Hoschke, B; May, M	1
Huo, D; Jin, JO; Lehmann, J; Stadler, WM; Steinberg, G; Stöckle, M; Taxy, J; Vogelzang, NJ	1
Campodonico, F; Canepa, G; Capponi, G; Fontana, V; Maffezzini, M	1
Calabrò, F; Sternberg, CN	1
Clenton, SJ; Ferguson, CJ; Kirkbride, P	1
Albanell, J; Carles, J; Doménech, M; Fabregat, X; Font, A; Gallén, M; Mesía, C; Nogué, M; Suárez, C; Suárez, M; Tusquets, I	1
Bartel, P; Ecke, TH; Koch, S; Ruttloff, J; Theissig, F	1
Aleknavicius, E; Asadauskiene, J; Jankevicius, F; Zelviene, TP	1
Aglianò, AM; Frati, L; Gandini, O; Gazzaniga, P; Gianni, W; Gradilone, A; Morrone, S; Scarpa, S; Silvestri, I	1
Aerts, R; De Boeck, G; De Bruijn, EA; Dumez, H; Guetens, G; Maes, RA; Martens, M; Selleslach, J; van Oosterom, AT	1
Alés, I; Baena, V; Benavides, M; Bretón, JJ; Carabante, F; Cobo, M; Contreras, J; Del Rosal, JM; Delgado, R; Fuentes, C; García, E; Gil, S; Herruzo, I; Moreno, P; Ruiz, JL; Villar, E	1
Siefker-Radtke, A	1
Amadori, D; Bertetto, O; Bono, A; Cartenì, G; Dogliotti, L; Marini, L; Martoni, A; Onat, H; Siena, S	1
Als, AB; Sengelov, L; von der Maase, H	2
Gschwend, JE	1
Akaza, H; Miki, T; Miyanaga, N; Naito, S; Taniai, H; Usami, M	1
Huang, WT; Kuo, CY; Li, SH	1
Fang, WJ; Qian, J; Xiong, JP; Xu, N; Yu, LF; Zhang, L; Zhang, XC	1
Brausi, MA	1
Albanell, J; Bellmunt, J; Berrocal, A; Carles, J; Climent, M; Esteban, E; Fabregat, X; Font, A; Garcia-Ribas, I; Gonzalez-Larriba, JL; Marfa, X	1
Baldazzi, V; Carini, M; Crisci, A; Giordano, C; Grifoni, R; Lapini, A; Neri, B; Pantaleo, P; Raugei, A; Vannini, L	1
Faerber, GJ; Weizer, AZ; Wolf, JS	1
Chen, HH; Cheng, YC; Lim, KH; Lin, CJ; Wu, CJ	1
Ballardini, M; Bercovich, E; Fiori, M; Frassineti, GL; Giovannini, N; Gunelli, R; Nanni, O; Pappagallo, GL; Pasquini, E; Silvestrini, R; Ulivi, P; Zoli, W	1
Chung, J; Han, KS; Jeong, IG; Joung, JY; Kim, TS; Lee, KH; Seo, HK	1
Bakirtas, H; Eroglu, M; Guvence, N; Ozok, HU; Ure, M	1
Atienza, D; Awasthi, S; Berry, W; Delaune, R; Deutsch, M; Dien, PY; Gregory, TF; Hood, K; Hutson, TE; Ilegbodu, D; Kolodziej, MJ; Mull, S; Muscato, JJ; Nicol, S; Raju, RN; Ruxer, RL; Vukelja, S	1
Bastos Oreiro, M; López Rodríguez, M; Monedero Martín, MC; Plasencia Rodríguez, C	1
Alivizatos, G; Antoniou, N; Bamias, A; Chrisofos, M; Dimopoulos, MA; Karayiotis, E; Kastritis, E; Koureas, A; Lainakis, G; Skolarikos, A	1
Agarwal, M; Beer, TM; Crawford, ED; Goldman, B; Nichols, CR; Petrylak, DP; Ryan, CW	1
Abi-Aad, AS	1
Dorr, FA; Kuzel, T; Raghavan, D; Roth, B; Stadler, WM	1
Ernst, DS; Huan, S; Moore, MJ; Murray, N; Tannock, IF	1
Antoine, EC; Khayat, D	1
Antimi, M; De Lena, M; Frassineti, GL; Gridelli, C; Lorusso, V; Luporini, G; Oliva, C; Pacini, M; Pollera, CF	1
Stadler, WM; Vogelzang, NJ	1
Bateman, AC; Cook, T; Dunsford, ML; Mead, GM; Tung, K	1
Bennett, K; Huan, S; Moore, MJ; Murray, N; Seymour, L; Tannock, IF; Walsh, W; Winquist, EW	1
Andersen, L; Crinò, L; Dogliotti, L; von der Maase, H; Weinknecht, S	1
Bajorin, DF; Boyle, MG; Dodd, PM; Herr, H; Hilton, S; Icasiano, E; Kelly, WK; Mazumdar, M; McCaffrey, JA	1
Sternberg, CN	2
Akaza, H; Hattori, K	1
Aisner, J; Carducci, M; Kaufman, D; Kuzel, T; Levine, EG; Murphy, B; Nicol, S; Oh, W; Raghavan, D; Stadler, W	1
Antimi, M; De Lena, M; De Vita, F; Lorusso, V; Manzione, L; Selvaggi, FP	1
Carles, J; Domènech, M; Guasch, I; Ibeas, R; Nogué, M; Pérez, C; Saigí, E; Villadiego, K	1
Albanell, J; Baselga, J; Bellmunt, J; Carles, J; Cortés-Funes, H; González-Larriba, JL; Guillem, V; Paz-Ares, L; Tabernero, JM	1
Burris, HS; Greco, FA; Hainsworth, JD; Meluch, AA	1
Bajorin, DF	1
Gaafar, R; Hamza, MR; Khaled, HM; Mansour, O; Zaghloul, MS	1
Albanell, J; Banús, JM; Baselga, J; Bastús, R; Batiste-Alentorn, E; Bellmunt, J; Carles, J; Climent, MA; Cortés-Funes, H; de la Cruz, JJ; Diaz-Rubio, E; Font, A; Gallardo, E; González-Larriba, JL; Guillem, V; López-Brea, M; Nogué, M; Paz-Ares, L; Sáenz, A	1
Albers, P; Bodrogi, I; Cleall, SP; Conte, PF; Dogliotti, L; Hansen, SW; Kerbrat, P; Knuth, A; Lippert, CM; Moore, MJ; Oliver, T; Roberts, JT; Roychowdhury, DF; Sanchez Rovira, P; Tomlin, I; Visseren-Grul, CM; von der Maase, H; Wersall, P	1
Edelman, MJ	1
Cohen, MH; Rothmann, M	1
Malkowicz, SB; Vaughn, DJ	1
Burris, HA; Greco, FA; Hainsworth, JD; Johnson, V; Meluch, AA; Morrissey, LH; O'Rourke, T; Ortega, G; Steis, RG	1
Albiol, S; Bellmunt, J	1
Carles, J; Nogué, M	1
Brooks, A; Crombie, C; Drummond, M; Gurney, H; Lau, H; Shannon, C	1
Calabrò, F; Marini, L; Pizzocaro, G; Schnetzer, S; Sella, A; Sternberg, CN	1
Athanassiou, A; Bountouroglou, N; Glotsos, J; Karvounis, N; Kouloubinis, A; Mitakidis, N; Pectasides, D; Ziras, N	1
Albers, P; Blatter, J; Fallahi, M; Haeutle, D; Härtlein, M; Müller, SC; Perabo, FG; Siener, R; Steiner, G	1
Stadler, WM	1
Hussain, M; Smith, DC; Vaishampayan, U	1
Daliani, D; Logothetis, CJ; Millikan, RE; Pagliaro, LC; Papandreou, CN; Tu, SM; Williams, D	1

Reviews

52 review(s) available for gemcitabine and Carcinoma, Transitional Cell

Article	Year
Systematic Literature Review and Meta-Analysis of Response to First-Line Therapies for Advanced/Metastatic Urothelial Cancer Patients Who Are Cisplatin Ineligible. American journal of clinical oncology, 2019, Volume: 42, Issue:10 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Disease-Free Survival; Eligibility Determination; Female; Gemcitabine; Humans; Male; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Survival Analysis; Treatment Outcome; Urologic Neoplasms	2019
Primary transitional cell carcinoma of the fallopian tube: A case report and literature review. Medicine, 2020, May-29, Volume: 99, Issue:22 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Fallopian Tube Neoplasms; Female; Gemcitabine; Humans; Hysterectomy; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Palliative Care; Salpingo-oophorectomy	2020
Chemoablation in Urothelial Carcinoma: A Systematic Review and Future Perspectives. Urology, 2020, Volume: 144 Topics: Administration, Intravesical; Antineoplastic Agents; Aziridines; BCG Vaccine; Carcinoma, Transitional Cell; Clinical Trials as Topic; Cystoscopy; Deoxycytidine; Epirubicin; Ethanol; Forecasting; Gemcitabine; Humans; Indolequinones; Injections, Intralesional; Interferon-alpha; Interleukin-2; Mitomycin; Urinary Bladder Neoplasms; Urothelium	2020
Nephron-sparing management of upper tract urothelial carcinoma. Investigative and clinical urology, 2021, Volume: 62, Issue:4 Topics: Adjuvants, Immunologic; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Carcinoma, Transitional Cell; Deoxycytidine; Gemcitabine; Humans; Kidney Neoplasms; Mitomycin; Neoplasm Staging; Nephrectomy; Nephrons; Organ Sparing Treatments; Ureteral Neoplasms; Ureteroscopy	2021
[New endovesical chemotherapy drugs and application vehicles.] Archivos espanoles de urologia, 2018, Volume: 71, Issue:4 Topics: Administration, Intravesical; Antineoplastic Agents; Carcinoma, Transitional Cell; Deoxycytidine; Gemcitabine; Humans; Urinary Bladder Neoplasms	2018
Immune checkpoint inhibitors for urothelial carcinoma. Investigative and clinical urology, 2018, Volume: 59, Issue:5 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Gemcitabine; Humans; Neoplasm Invasiveness; Nivolumab; Ureteral Neoplasms; Urinary Bladder Neoplasms	2018
SIU-ICUD recommendations on bladder cancer: systemic therapy for metastatic bladder cancer. World journal of urology, 2019, Volume: 37, Issue:1 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Liver Neoplasms; Methotrexate; Nivolumab; Paclitaxel; Urinary Bladder Neoplasms; Vinblastine	2019
Second Line Chemotherapy for Advanced and Metastatic Urothelial Carcinoma: Vinflunine and Beyond-A Comprehensive Review of the Current Literature. The Journal of urology, 2016, Volume: 195, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Biological Factors; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Indazoles; Neoplasm Recurrence, Local; Paclitaxel; Pemetrexed; Pyrimidines; Salvage Therapy; Sulfonamides; Urinary Bladder Neoplasms; Vinblastine	2016
Neoadjuvant Chemotherapy With Gemcitabine and Cisplatin for Plasmacytoid Urothelial Bladder Cancer: A Case Report and Review of the Literature. Clinical genitourinary cancer, 2016, Volume: 14, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Humans; Male; Middle Aged; Neoadjuvant Therapy; Treatment Outcome; Ultrasonography; Urinary Bladder Neoplasms	2016
Pathological T0 Following Cisplatin-Based Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Network Meta-analysis. Clinical cancer research : an official journal of the American Association for Cancer Research, 2016, Mar-01, Volume: 22, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Carcinoma, Transitional Cell; Cisplatin; Cystectomy; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Methotrexate; Neoadjuvant Therapy; Neoplasm Invasiveness; Urinary Bladder Neoplasms; Vinblastine	2016
Efficacy and Safety of Gemcitabine Plus Either Taxane or Carboplatin in the First-Line Setting of Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis. Clinical genitourinary cancer, 2017, Volume: 15, Issue:1 Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Transitional Cell; Clinical Trials as Topic; Deoxycytidine; Gemcitabine; Humans; Neoplasm Metastasis; Survival Analysis; Taxoids; Treatment Outcome; Urologic Neoplasms	2017
Upper tract urothelial carcinoma topical issue 2016: treatment of metastatic cancer. World journal of urology, 2017, Volume: 35, Issue:3 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Immunotherapy; Indoles; Kidney Neoplasms; Kidney Pelvis; Niacinamide; Paclitaxel; Phenylurea Compounds; Pyrroles; Sorafenib; Sunitinib; Taxoids; Ureteral Neoplasms	2017
Definitive Management of Primary Bladder Tumors in the Context of Metastatic Disease: Who, How, When, and Why? Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, 10-10, Volume: 34, Issue:29 Topics: Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Carcinoma, Transitional Cell; Cisplatin; Cystectomy; Deoxycytidine; Gemcitabine; Humans; Immunotherapy; Lymphatic Metastasis; Male; Pelvis; Radiotherapy; Retroperitoneal Space; Urinary Bladder Neoplasms	2016
Bladder chondrosarcoma plus urothelial carcinoma in recurred transitional cell carcinoma of the upper urinary tract: a case report and literature review. World journal of surgical oncology, 2016, Oct-20, Volume: 14, Issue:1 Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Chondrosarcoma; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Kidney; Kidney Neoplasms; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Tomography, X-Ray Computed; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Surgical Procedures	2016
Emerging role of immunotherapy in urothelial carcinoma-Advanced disease. Urologic oncology, 2016, Volume: 34, Issue:12 Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Biomarkers, Tumor; Cancer Vaccines; Carcinoma, Transitional Cell; Cisplatin; Clinical Trials as Topic; CTLA-4 Antigen; Deoxycytidine; Gemcitabine; Humans; Immunotherapy; Ipilimumab; Molecular Targeted Therapy; Neoplasm Proteins; Nivolumab; Oncolytic Virotherapy; Programmed Cell Death 1 Receptor; Therapies, Investigational; Urinary Bladder Neoplasms	2016
Lymphoepithelioma-Like Bladder Carcinoma: A Diagnostic and Therapeutic Challenge. Contribution Using a New Case and Review of the Literature. Clinical genitourinary cancer, 2017, Volume: 15, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Middle Aged; Urinary Bladder Neoplasms	2017
Systemic therapy for unresectable and metastatic transitional cell carcinoma of the urothelium: first-line and beyond. Current opinion in supportive and palliative care, 2008, Volume: 2, Issue:3 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Drug Administration Schedule; Gemcitabine; Humans; Paclitaxel; Receptor, ErbB-2; Trastuzumab; Urologic Neoplasms; Urothelium	2008
Gemcitabine and carboplatin in the treatment of transitional cell carcinoma of the urothelium: a single centre experience and review of the literature. European journal of cancer care, 2010, Volume: 19, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Survival Analysis; Urinary Bladder Neoplasms	2010
Gemcitabine for unresectable, locally advanced or metastatic bladder cancer. The Cochrane database of systematic reviews, 2011, Apr-13, Issue:4 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Methotrexate; Paclitaxel; Randomized Controlled Trials as Topic; Urinary Bladder Neoplasms; Vinblastine	2011
Gemcitabine chemotherapy for the treatment of metastatic bladder carcinoma. BJU international, 2011, Volume: 108, Issue:2 Topics: Antineoplastic Agents; Carcinoma, Transitional Cell; Deoxycytidine; Gemcitabine; Humans; Prognosis; Randomized Controlled Trials as Topic; Treatment Outcome; Urinary Bladder Neoplasms	2011
Systemic chemotherapy in patients with advanced transitional cell carcinoma of the urothelium and impaired renal function. Anti-cancer drugs, 2012, Volume: 23, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Deoxycytidine; Disease-Free Survival; Gemcitabine; Humans; Kidney; Kidney Function Tests; Neoplasm Invasiveness; Paclitaxel; Randomized Controlled Trials as Topic; Urologic Neoplasms; Urothelium	2012
Pathological vertebral fracture after stereotactic body radiation therapy for lung metastases. Case report and literature review. Radiation oncology (London, England), 2012, Mar-28, Volume: 7 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Density; Carboplatin; Carcinoma, Transitional Cell; Cervical Vertebrae; Cisplatin; Combined Modality Therapy; Deoxycytidine; Female; Fractures, Spontaneous; Gemcitabine; Glutamates; Guanine; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Osteoporosis, Postmenopausal; Pemetrexed; Radiosurgery; Radiotherapy, Conformal; Rib Fractures; Ribs; Spinal Fractures; Thoracic Vertebrae; Urinary Bladder Neoplasms	2012
Experience with newer intravesical chemotherapy for high-risk non-muscle-invasive bladder cancer. Current urology reports, 2013, Volume: 14, Issue:2 Topics: Administration, Intravesical; Antineoplastic Agents; BCG Vaccine; Carcinoma, Transitional Cell; Deoxycytidine; Docetaxel; Doxorubicin; Gemcitabine; Humans; Mitomycin; Paclitaxel; Taxoids; Thiotepa; Treatment Failure; Urinary Bladder Neoplasms	2013
Docetaxel in the management of advanced or metastatic urothelial tract cancer. Oncology (Williston Park, N.Y.), 2002, Volume: 16, Issue:6 Suppl 6 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Clinical Trials, Phase II as Topic; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Paclitaxel; Taxoids; Urologic Neoplasms	2002
Gemcitabine and radiotherapy in the treatment of brain metastases from transitional cell carcinoma of the bladder: a case report. Journal of neuro-oncology, 2002, Volume: 57, Issue:2 Topics: Antimetabolites, Antineoplastic; Brain Neoplasms; Carcinoma, Transitional Cell; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Urinary Bladder Neoplasms	2002
[Gemcitabine in advanced bladder cancer]. Der Urologe. Ausg. A, 2003, Volume: 42, Issue:1 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Clinical Trials as Topic; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Gemcitabine; Humans; Neoplasm Staging; Salvage Therapy; Survival Rate; Urinary Bladder Neoplasms	2003
Gemcitabine in transitional cell carcinoma of the urothelium. Expert review of anticancer therapy, 2003, Volume: 3, Issue:1 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Gemcitabine; Humans; Urologic Neoplasms; Urothelium	2003
[Role of gemcitabine/cisplatin in the treatment of advanced and metastatic bladder cancer]. Magyar onkologia, 2003, Volume: 47, Issue:2 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Staging; Randomized Controlled Trials as Topic; Treatment Outcome; Urinary Bladder Neoplasms	2003
Analysis of treatment for small cell cancer of the bladder and report of three cases. Urology, 2004, Volume: 64, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Biomarkers, Tumor; Bone Neoplasms; Carboplatin; Carcinoma, Small Cell; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Deoxycytidine; Disease Progression; Etoposide; Gemcitabine; Humans; Life Tables; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasms, Second Primary; Prostatectomy; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms; Urinary Diversion	2004
Pemetrexed in transitional cell carcinoma of the urothelium. Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:13 Suppl 8 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Clinical Trials, Phase II as Topic; Deoxycytidine; Folic Acid Antagonists; Gemcitabine; Glutamates; Guanine; Humans; Pemetrexed; Thymidylate Synthase; Urologic Neoplasms; Urothelium	2004
Gemcitabine in the treatment of advanced transitional cell carcinoma of the urothelium. Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17 Suppl 5 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Comorbidity; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Methotrexate; Pharmacogenetics; Prognosis; Renal Insufficiency; Urinary Bladder Neoplasms; Urothelium; Vinblastine	2006
Intravesical gemcitabine: an update of clinical results. Current opinion in urology, 2006, Volume: 16, Issue:5 Topics: Administration, Intravesical; Animals; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Clinical Trials as Topic; Deoxycytidine; Disease Progression; Gemcitabine; Humans; Recurrence; Treatment Outcome; Urinary Bladder Neoplasms	2006
State-of-the-art management of metastatic disease at initial presentation or recurrence. World journal of urology, 2006, Volume: 24, Issue:5 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Disease-Free Survival; Docetaxel; Gemcitabine; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Taxoids; Urinary Bladder Neoplasms	2006
[Bladder preservation possibilities in the treatment of muscle-invasive bladder cancer]. Medicina (Kaunas, Lithuania), 2006, Volume: 42, Issue:10 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cystectomy; Deoxycytidine; Disease-Free Survival; Dose Fractionation, Radiation; Doxorubicin; Gemcitabine; Humans; Methotrexate; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Radiation-Sensitizing Agents; Radiotherapy Dosage; Taxoids; Time Factors; Urinary Bladder; Urinary Bladder Neoplasms; Vinblastine	2006
Urachal carcinoma: surgical and chemotherapeutic options. Expert review of anticancer therapy, 2006, Volume: 6, Issue:12 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cystectomy; Deoxycytidine; Diagnosis, Differential; Female; Fluorouracil; Gemcitabine; Hematuria; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Risk Factors; Umbilicus; Urachal Cyst; Urachus; Urinary Bladder Neoplasms	2006
New strategies in the treatment of Ta-T1 transitional cell carcinoma (TCC) of the bladder. TheScientificWorldJournal, 2006, Oct-02, Volume: 6 Topics: Antineoplastic Agents; Carcinoma, Transitional Cell; Deoxycytidine; Drug Delivery Systems; Gemcitabine; Genetic Therapy; Humans; Hyperthermia, Induced; Immunotherapy; Medical Oncology; Microwaves; Urinary Bladder Neoplasms; Urology	2006
Chemotherapy for advanced bladder carcinoma: new molecules and regimens. Acta urologica Belgica, 1996, Volume: 64, Issue:2 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Folic Acid Antagonists; Gallium; Gemcitabine; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Methotrexate; Paclitaxel; Urinary Bladder Neoplasms; Vinblastine	1996
[The role of new drugs in the treatment of locally advanced urothelial tumors of the bladder]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 1998, Volume: 2 Suppl 1 Topics: Antineoplastic Agents; Carcinoma, Transitional Cell; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Neoplasm Invasiveness; Paclitaxel; Taxoids; Urinary Bladder Neoplasms	1998
Gemcitabine and other new chemotherapeutic agents for the treatment of metastatic bladder cancer. Urology, 1999, Volume: 53, Issue:2 Topics: Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Clinical Trials as Topic; Deoxycytidine; Gemcitabine; Humans; Urinary Bladder Neoplasms	1999
Gemcitabine in bladder cancer. Seminars in oncology, 2000, Volume: 27, Issue:1 Suppl 2 Topics: Angiogenesis Inhibitors; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Transitional Cell; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Gemcitabine; Granulocyte Colony-Stimulating Factor; Humans; Prognosis; Urinary Bladder Neoplasms	2000
[New combination chemotherapy in urological cancers]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Docetaxel; Doxorubicin; Drug Administration Schedule; Female; Gemcitabine; Humans; Interferon-alpha; Interleukin-2; Kidney Neoplasms; Male; Methotrexate; Paclitaxel; Prostatic Neoplasms; Taxoids; Testicular Neoplasms; Urinary Bladder Neoplasms; Vinblastine	2000
Gemcitabine and cisplatin in locally advanced and/or metastatic bladder cancer. European journal of cancer (Oxford, England : 1990), 2000, Volume: 36 Suppl 2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Clinical Trials, Phase II as Topic; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Methotrexate; Urinary Bladder Neoplasms; Vinblastine	2000
Gemcitabine/paclitaxel-based three-drug regimens in advanced urothelial cancer. European journal of cancer (Oxford, England : 1990), 2000, Volume: 36 Suppl 2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclophosphamide; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Paclitaxel; Urinary Bladder Neoplasms; Vinblastine	2000
Gemcitabine and paclitaxel combination therapy in transitional cell carcinoma of the urothelium. European journal of cancer (Oxford, England : 1990), 2000, Volume: 36 Suppl 2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Clinical Trials, Phase II as Topic; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Paclitaxel; Urologic Neoplasms	2000
New approaches to treatment of metastatic bladder cancer. Current oncology reports, 2000, Volume: 2, Issue:5 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Gallium; Gemcitabine; Humans; Ifosfamide; Methotrexate; Neoplasm Metastasis; Taxoids; Urinary Bladder Neoplasms; Vinblastine	2000
Recent advances in bladder cancer chemotherapy. Cancer investigation, 2001, Volume: 19, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Neoadjuvant Therapy; Paclitaxel; Randomized Controlled Trials as Topic; Taxoids; Urinary Bladder Neoplasms	2001
Second-line treatment of advanced transitional cell carcinoma of the urothelial tract. Current opinion in urology, 2001, Volume: 11, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Male; Methotrexate; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Randomized Controlled Trials as Topic; Severity of Illness Index; Survival Analysis; Taxoids; Treatment Outcome; Urinary Bladder Neoplasms; Urologic Neoplasms; Urothelium; Vinblastine	2001
New chemotherapy combinations for advanced bladder cancer. Current opinion in urology, 2001, Volume: 11, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Transitional Cell; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Drug Combinations; Female; Gemcitabine; Humans; Male; Methotrexate; Neoplasm Metastasis; Platinum; Prognosis; Severity of Illness Index; Survival Analysis; Taxoids; Urinary Bladder Neoplasms; Vinblastine	2001
Gemcitabine/carboplatin in advanced urothelial cancer. Seminars in oncology, 2001, Volume: 28, Issue:3 Suppl 10 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Clinical Trials as Topic; Deoxycytidine; Female; Gemcitabine; Humans; Male; Urinary Bladder Neoplasms	2001
Current and future perspectives in advanced bladder cancer: is there a new standard? Seminars in oncology, 2002, Volume: 29, Issue:1 Suppl 3 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Forecasting; Gemcitabine; Humans; Ifosfamide; Methotrexate; Neoplasm Metastasis; Paclitaxel; Patient Selection; Practice Guidelines as Topic; Research Design; Risk Factors; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine	2002
Gemcitabine doublets in advanced urothelial cancer. Seminars in oncology, 2002, Volume: 29, Issue:1 Suppl 3 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Clinical Trials, Phase II as Topic; Deoxycytidine; Doxorubicin; Forecasting; Gemcitabine; Humans; Methotrexate; Neoplasm Metastasis; Neoplasm Staging; Paclitaxel; Prognosis; Renal Insufficiency; Survival Analysis; Trastuzumab; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine	2002
Novel gemcitabine-containing triplets in the management of urothelial cancer. Seminars in oncology, 2002, Volume: 29, Issue:1 Suppl 3 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Clinical Trials, Phase II as Topic; Deoxycytidine; Doxorubicin; Forecasting; Gemcitabine; Humans; Methotrexate; Neoplasm Metastasis; Neoplasm Staging; Paclitaxel; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine	2002

Trials

127 trial(s) available for gemcitabine and Carcinoma, Transitional Cell

Article	Year
Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder. Investigative and clinical urology, 2022, Volume: 63, Issue:2 Topics: Carcinoma, Transitional Cell; Chemoradiotherapy; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Male; Muscles; Neoadjuvant Therapy; Prospective Studies; Urinary Bladder; Urinary Bladder Neoplasms	2022
Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients With Nonmetastatic Muscle-Invasive Bladder Cancer: Results of the GETUG-AFU V05 VESPER Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022, 06-20, Volume: 40, Issue:18 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Methotrexate; Muscles; Neoadjuvant Therapy; Urinary Bladder Neoplasms; Vinblastine	2022
Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023, 03-10, Volume: 41, Issue:8 Topics: Carcinoma, Transitional Cell; Cisplatin; Gemcitabine; Humans; Neoadjuvant Therapy; Urinary Bladder Neoplasms	2023
Adjuvant vs. progression-triggered treatment with gemcitabine in platinum-ineligible high-risk bladder cancer patients: Long-term follow-up of a randomized phase 3 trial. Urologic oncology, 2023, Volume: 41, Issue:8 Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Follow-Up Studies; Gemcitabine; Humans; Platinum; Quality of Life; Urinary Bladder; Urinary Bladder Neoplasms	2023
Acute Toxicity of Hypofractionated and Conventionally Fractionated (Chemo)Radiotherapy Regimens for Bladder Cancer: An Exploratory Analysis from the RAIDER Trial. Clinical oncology (Royal College of Radiologists (Great Britain)), 2023, Volume: 35, Issue:9 Topics: Aged; Brachytherapy; Carcinoma, Transitional Cell; Gemcitabine; Humans; Mitomycin; Radiation Oncology; Urinary Bladder Neoplasms	2023
Design and rationale of a single-arm phase II study of neoadjuvant Durvalumab and Gemcitabine associated with Cisplatin or Carboplatin for upper urinary tract urothelial cancer: the iNDUCT trial (NCT04617756). World journal of urology, 2023, Volume: 41, Issue:12 Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Gemcitabine; Humans; Kidney Neoplasms; Kidney Pelvis; Neoadjuvant Therapy; Retrospective Studies; Ureteral Neoplasms; Urinary Bladder Neoplasms	2023
Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma. The New England journal of medicine, 2023, Nov-09, Volume: 389, Issue:19 Topics: Administration, Intravenous; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Gemcitabine; Humans; Nivolumab; Urinary Bladder Neoplasms	2023
A Phase I Trial of Intravesical Cabazitaxel, Gemcitabine and Cisplatin for the Treatment of Nonmuscle Invasive bacillus Calmette-Guérin Unresponsive or Recurrent/Relapsing Urothelial Carcinoma of the Bladder. The Journal of urology, 2020, Volume: 204, Issue:2 Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Dose-Response Relationship, Drug; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Taxoids; Urinary Bladder Neoplasms	2020
A randomised Phase II trial of carboplatin and gemcitabine ± vandetanib in first-line treatment of patients with advanced urothelial cell cancer not suitable to receive cisplatin. BJU international, 2020, Volume: 126, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Double-Blind Method; Drug Combinations; Female; Gemcitabine; Humans; Male; Neoplasm Staging; Piperidines; Quinazolines; Treatment Outcome	2020
Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma: A Phase 2 Randomized Clinical Trial. JAMA oncology, 2021, Oct-01, Volume: 7, Issue:10 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Isoxazoles; Male; Pyrazines; Treatment Outcome; Urinary Bladder Neoplasms	2021
Neoadjuvant Chemotherapy with Gemcitabine plus Cisplatin in Patients with Locally Advanced Bladder Cancer. Oncology, 2017, Volume: 93, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Neoadjuvant Therapy; Prospective Studies; Treatment Outcome; Urinary Bladder Neoplasms	2017
Adjuvant Sandwich Chemotherapy Plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy: A Randomized Phase 2 Trial. JAMA surgery, 2018, 01-17, Volume: 153, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Urinary Bladder Neoplasms	2018
Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes. European urology, 2018, Volume: 73, Issue:5 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Disease-Free Survival; DNA Damage; DNA Mutational Analysis; Female; Gemcitabine; Humans; Ipilimumab; Kaplan-Meier Estimate; Male; Middle Aged; Molecular Targeted Therapy; Mutation; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Prospective Studies; Risk Assessment; Survival Analysis; Treatment Outcome; Urologic Neoplasms	2018
Phase I combination study of the PARP inhibitor veliparib plus carboplatin and gemcitabine in patients with advanced ovarian cancer and other solid malignancies. Gynecologic oncology, 2018, Volume: 148, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bayes Theorem; Benzimidazoles; Bile Duct Neoplasms; Breast Neoplasms; Carboplatin; Carcinoma, Basal Cell; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cholangiocarcinoma; Deoxycytidine; Female; Gallbladder Neoplasms; Gemcitabine; Genes, BRCA1; Genes, BRCA2; Germ-Line Mutation; Humans; Induction Chemotherapy; Kidney Neoplasms; Kidney Pelvis; Liver Neoplasms; Lung Neoplasms; Maintenance Chemotherapy; Male; Maximum Tolerated Dose; Mesothelioma; Middle Aged; Nausea; Neoplasm Metastasis; Neutropenia; Ovarian Neoplasms; Poly(ADP-ribose) Polymerase Inhibitors; Prostatic Neoplasms; Skin Neoplasms; Thrombocytopenia; Treatment Outcome	2018
Pembrolizumab Combined With Either Docetaxel or Gemcitabine in Patients With Advanced or Metastatic Platinum-Refractory Urothelial Cancer: Results From a Phase I Study. Clinical genitourinary cancer, 2018, Volume: 16, Issue:6 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Docetaxel; Drug Resistance, Neoplasm; Feasibility Studies; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Platinum Compounds; Progression-Free Survival; Response Evaluation Criteria in Solid Tumors; Urologic Neoplasms	2018
Multicenter Phase 2 Trial of Gemcitabine, Carboplatin, and Sorafenib in Patients With Metastatic or Unresectable Transitional-Cell Carcinoma. Clinical genitourinary cancer, 2018, Volume: 16, Issue:6 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Deoxycytidine; Disease Progression; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Middle Aged; Progression-Free Survival; Sorafenib; Survival Analysis; Urologic Neoplasms	2018
The impact of intravesical gemcitabine and 1/3 dose Bacillus Calmette-Guérin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: results of a prospective, randomized, phase II trial. The Journal of urology, 2013, Volume: 190, Issue:3 Topics: Administration, Intravesical; BCG Vaccine; Carcinoma, Transitional Cell; Deoxycytidine; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Quality of Life; Risk Assessment; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms	2013
Treatment outcomes of paclitaxel for refractory or recurrent epithelial ovarian cancer patients in Thailand. Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:4 Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Serous; Deoxycytidine; Drug Resistance, Neoplasm; Endometrial Neoplasms; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prognosis; Survival Rate	2013
Larotaxel with Cisplatin in the first-line treatment of locally advanced/metastatic urothelial tract or bladder cancer: a randomized, active-controlled, phase III trial (CILAB). Oncology, 2013, Volume: 85, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Survival Analysis; Taxoids; Treatment Outcome; Urinary Bladder Neoplasms; Urothelium	2013
A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma. Cancer, 2014, Sep-01, Volume: 120, Issue:17 Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cadherins; Carcinoma, Transitional Cell; Cetuximab; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Proportional Hazards Models; Treatment Outcome; Urinary Bladder Neoplasms	2014
Gemcitabine and cisplatin as neoadjuvant chemotherapy for invasive transitional and squamous cell carcinoma of the bladder: effect on survival and bladder preservation. Clinical genitourinary cancer, 2014, Volume: 12, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Cystectomy; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Male; Middle Aged; Neoadjuvant Therapy; Prospective Studies; Treatment Outcome; Urinary Bladder; Urinary Bladder Neoplasms	2014
Combined chemoradiotherapy with gemcitabine in patients with locally advanced inoperable transitional cell carcinoma of the urinary bladder and/or in patients ineligible for surgery: a phase I trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2014, Volume: 25, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Chemoradiotherapy; Combined Modality Therapy; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Maximum Tolerated Dose; Middle Aged; Radiation-Sensitizing Agents; Urinary Bladder; Urinary Bladder Neoplasms	2014
Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2. European journal of cancer (Oxford, England : 1990), 2015, Volume: 51, Issue:1 Topics: Aged; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Platinum; Receptor, ErbB-2; Trastuzumab	2015
A Phase II Study of the Central European Society of Anticancer-Drug Research (CESAR) Group: Results of an Open-Label Study of Gemcitabine plus Cisplatin with or without Concomitant or Sequential Gefitinib in Patients with Advanced or Metastatic Transition Urologia internationalis, 2016, Volume: 96, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Disease Progression; Drug Administration Schedule; ErbB Receptors; Female; Gefitinib; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Quinazolines; Treatment Outcome; Urinary Bladder Neoplasms; Urothelium	2016
Safety and efficacy of combination therapy with low-dose gemcitabine, paclitaxel, and sorafenib in patients with cisplatin-resistant urothelial cancer. Medical oncology (Northwood, London, England), 2015, Volume: 32, Issue:10 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Niacinamide; Paclitaxel; Pain Measurement; Phenylurea Compounds; Quality of Life; Sorafenib; Urinary Bladder Neoplasms	2015
Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1). Annals of oncology : official journal of the European Society for Medical Oncology, 2016, Volume: 27, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Male; Middle Aged; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine	2016
Long-Term Outcomes Among Patients Who Achieve Complete or Near-Complete Responses After the Induction Phase of Bladder-Preserving Combined-Modality Therapy for Muscle-Invasive Bladder Cancer: A Pooled Analysis of NRG Oncology/RTOG 9906 and 0233. International journal of radiation oncology, biology, physics, 2016, Jan-01, Volume: 94, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Consolidation Chemotherapy; Cystectomy; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Organ Sparing Treatments; Paclitaxel; Prospective Studies; Radiotherapy Dosage; Remission Induction; Salvage Therapy; Urinary Bladder Neoplasms	2016
Front-line Treatment with Gemcitabine, Paclitaxel, and Doxorubicin for Patients With Unresectable or Metastatic Urothelial Cancer and Poor Renal Function: Final Results from a Phase II Study. Urology, 2016, Volume: 89 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Transitional Cell; Deoxycytidine; Doxorubicin; Drug Therapy, Combination; Female; Filgrastim; Gemcitabine; Granulocyte Colony-Stimulating Factor; Humans; Kidney; Male; Middle Aged; Paclitaxel; Polyethylene Glycols; Recombinant Proteins; Renal Insufficiency; Urologic Neoplasms	2016
Phase II trial of paclitaxel, carboplatin and gemcitabine in patients with locally advanced carcinoma of the bladder. The Journal of urology, 2008, Volume: 180, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Urinary Bladder Neoplasms	2008
Combined-modality therapy with gemcitabine and radiation therapy as a bladder preservation strategy: long-term results of a phase I trial. International journal of radiation oncology, biology, physics, 2009, Jun-01, Volume: 74, Issue:2 Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystectomy; Deoxycytidine; Drug Administration Schedule; Gemcitabine; Humans; Male; Middle Aged; Salvage Therapy; Survival Analysis; Urinary Bladder Neoplasms	2009
A phase II trial of cisplatin (C), gemcitabine (G) and gefitinib for advanced urothelial tract carcinoma: results of Cancer and Leukemia Group B (CALGB) 90102. Annals of oncology : official journal of the European Society for Medical Oncology, 2009, Volume: 20, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gefitinib; Gemcitabine; Humans; Male; Middle Aged; Quinazolines; Urologic Neoplasms	2009
Intra-arterial chemotherapy with gemcitabine and cisplatin for patients with recurrence of transitional cell carcinoma confined to the pelvis. Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Infusions, Intra-Arterial; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Pelvic Neoplasms; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2009
A sequential treatment approach to myoinvasive urothelial cancer: a phase II Southwest Oncology Group trial (S0219). The Journal of urology, 2009, Volume: 181, Issue:6 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cystectomy; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Paclitaxel; Urinary Bladder Neoplasms	2009
Single postoperative instillation of gemcitabine in patients with non-muscle-invasive transitional cell carcinoma of the bladder: a randomised, double-blind, placebo-controlled phase III multicentre study. European urology, 2009, Volume: 56, Issue:3 Topics: Administration, Intravesical; Aged; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Combined Modality Therapy; Deoxycytidine; Double-Blind Method; Female; Gemcitabine; Humans; Male; Postoperative Care; Urinary Bladder Neoplasms	2009
Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Sep-01, Volume: 27, Issue:25 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Disease-Free Survival; Doxorubicin; Female; Gemcitabine; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Paclitaxel; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms; Urothelium	2009
Randomized phase II/III trial assessing gemcitabine/ carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer "unfit" for cisplatin-based chemotherapy: phase II--results of EORTC study 30986. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Nov-20, Volume: 27, Issue:33 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Maximum Tolerated Dose; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Survival Analysis; Treatment Outcome; Urologic Neoplasms; Urothelium; Vinblastine	2009
Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and tolerance. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Feb-01, Volume: 28, Issue:4 Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Deoxycytidine; Female; Gemcitabine; Humans; Male; Maximum Tolerated Dose; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Survival Rate; Treatment Outcome; Urinary Bladder Neoplasms	2010
Randomized phase III trial of 2nd line gemcitabine and paclitaxel chemotherapy in patients with advanced bladder cancer: short-term versus prolonged treatment [German Association of Urological Oncology (AUO) trial AB 20/99]. Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Disease Progression; Disease-Free Survival; Gemcitabine; Humans; Middle Aged; Paclitaxel; Prognosis; Urinary Bladder Neoplasms	2011
Gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer: Long-term cumulative results of 2 prospective single-institution studies. Cancer, 2011, Mar-15, Volume: 117, Issue:6 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Deoxycytidine; Follow-Up Studies; Gemcitabine; Humans; Middle Aged; Neoplasm Invasiveness; Survival Rate; Time Factors; Urinary Bladder Neoplasms	2011
Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Feb-20, Volume: 29, Issue:6 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Transitional Cell; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Muscle Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Radiotherapy, Conformal; Urinary Bladder Neoplasms	2011
Toxic effects and antitumor response of gemcitabine in combination with piroxicam treatment in dogs with transitional cell carcinoma of the urinary bladder. Journal of the American Veterinary Medical Association, 2011, Apr-15, Volume: 238, Issue:8 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Deoxycytidine; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Gemcitabine; Male; Piroxicam; Urinary Bladder Neoplasms	2011
[First line therapy for local advanced or metastatic urothelial cell carcinoma: randomized phase II study to investigate the combination of vinflunine with gemcitabine and vinflunine with carboplatin in patients unfit for cisplatin therapy with advanced o Der Urologe. Ausg. A, 2011, Volume: 50, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Disease Progression; Female; Gemcitabine; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Staging; Urinary Bladder Neoplasms; Vinblastine	2011
Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Italy; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Recurrence; Urinary Bladder Neoplasms	2012
Phase I study of radiochemotherapy with gemcitabine in invasive bladder cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2012, Volume: 102, Issue:3 Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Chemoradiotherapy; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Invasiveness; Urinary Bladder Neoplasms	2012
Combination of gemcitabine and paclitaxel is a favorable option for patients with advanced or metastatic urothelial carcinoma previously treated with cisplatin-based chemotherapy. Japanese journal of clinical oncology, 2011, Volume: 41, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Disease-Free Survival; Doxorubicin; Female; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Paclitaxel; Survival Analysis; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine	2011
Phase II study of a cremophor-free, polymeric micelle formulation of paclitaxel for patients with advanced urothelial cancer previously treated with gemcitabine and platinum. Investigational new drugs, 2012, Volume: 30, Issue:5 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemistry, Pharmaceutical; Cisplatin; Deoxycytidine; Disease Progression; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Micelles; Middle Aged; Organoplatinum Compounds; Paclitaxel; Polyethylene Glycols; Polymers; Prognosis; Urologic Neoplasms	2012
[First line therapy for local advanced or metastasized urothelial carcinoma: randomized double-blind phase II study to compare gemcitabin and cisplatin in combination with OGX-427 or placebo for advanced transitional cell carcinoma of the bladder (OGX-427 Der Urologe. Ausg. A, 2011, Volume: 50, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Double-Blind Method; Gemcitabine; Humans; Placebo Effect; Treatment Outcome; Urinary Bladder Neoplasms	2011
Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Apr-01, Volume: 30, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Gemcitabine; Hemorrhage; Humans; Male; Middle Aged; Neutropenia; Paclitaxel; Survival Analysis; Thrombocytopenia; Treatment Outcome; Urologic Neoplasms; Urothelium	2012
[The efficacy and toxicity of gemcitabine and cisplatin chemotherapy in advanced/metastatic bladder urothelial carcinoma]. Actas urologicas espanolas, 2012, Volume: 36, Issue:9 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Deoxycytidine; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neutropenia; Salvage Therapy; Thrombocytopenia; Treatment Outcome; Urinary Bladder Neoplasms	2012
Methotrexate-paclitaxel-epirubicin-carboplatin as second-line chemotherapy in patients with metastatic transitional cell carcinoma of the bladder pretreated with cisplatin-gemcitabine: a phase II study. Asia-Pacific journal of clinical oncology, 2013, Volume: 9, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Staging; Paclitaxel; Prognosis; Prospective Studies; Salvage Therapy; Survival Rate; Urinary Bladder Neoplasms	2013
A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results. Cancer, 2013, Feb-01, Volume: 119, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Drug Administration Schedule; Female; Gemcitabine; Humans; Ifosfamide; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms; Urothelium	2013
Gemcitabine, Cisplatin, and sunitinib for metastatic urothelial carcinoma and as preoperative therapy for muscle-invasive bladder cancer. Clinical genitourinary cancer, 2013, Volume: 11, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Indoles; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Pyrroles; Sunitinib; Survival Rate; Urinary Bladder Neoplasms; Urothelium	2013
Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Aug-01, Volume: 20, Issue:15 Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; BCG Vaccine; Carcinoma, Transitional Cell; Deoxycytidine; Dose-Response Relationship, Drug; Female; Gemcitabine; Humans; Male; Middle Aged; Treatment Outcome; Urinary Bladder Neoplasms	2002
Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine. Cancer, 2002, Aug-15, Volume: 95, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Survival Analysis; Urinary Bladder Neoplasms; Urologic Neoplasms; Urothelium	2002
Intravesical gemcitabine therapy for superficial transitional cell carcinoma of the bladder: a phase I and pharmacokinetic study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Feb-15, Volume: 21, Issue:4 Topics: Administration, Intravesical; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Chromatography, High Pressure Liquid; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Urinary Bladder Neoplasms	2003
Gemcitabine combined with sequential paclitaxel and carboplatin in patients with urothelial cancers and other advanced malignancies. Medical science monitor : international medical journal of experimental and clinical research, 2003, Volume: 9, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cell Survival; Cohort Studies; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasms; Paclitaxel; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Urothelium	2003
Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract: an alternative therapy. Cancer, 2003, May-01, Volume: 97, Issue:9 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Deoxycytidine; Female; Gemcitabine; Humans; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Quality of Life; Survival Rate; Urologic Neoplasms	2003
Phase II trial of gemcitabine and docetaxel in patients with advanced carcinoma of the urothelium: a trial of the Eastern Cooperative Oncology Group. Cancer, 2003, Jun-01, Volume: 97, Issue:11 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Docetaxel; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Middle Aged; Paclitaxel; Taxoids; Urologic Neoplasms; Urothelium	2003
Gemcitabine plus cisplatin in adjuvant regimen for bladder cancer. Toxicity evaluation. Urologia internationalis, 2003, Volume: 71, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Deoxycytidine; Drug Therapy, Combination; Gemcitabine; Humans; Middle Aged; Treatment Outcome; Urinary Bladder Neoplasms	2003
[Gemcitabine/cisplatin vs. MVAC. 5 year survival outcome of the phase III study of chemotherapy of advanced urothelial carcinoma in Germany]. Der Urologe. Ausg. A, 2003, Volume: 42, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Disease Progression; Doxorubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Staging; Palliative Care; Prospective Studies; Survival Rate; Urologic Neoplasms; Vinblastine	2003
A phase II study of gemcitabine and docetaxel therapy in patients with advanced urothelial carcinoma. Cancer, 2003, Nov-01, Volume: 98, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Male; Middle Aged; Neutropenia; Paclitaxel; Taxoids; Treatment Outcome; Urinary Bladder Neoplasms	2003
Phase I study of gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer. International journal of radiation oncology, biology, physics, 2003, Dec-01, Volume: 57, Issue:5 Topics: Aged; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Deoxycytidine; Drug Administration Schedule; Drug Therapy, Combination; Female; Gemcitabine; Humans; Male; Maximum Tolerated Dose; Middle Aged; Quality of Life; Radiation-Sensitizing Agents; Treatment Outcome; Urinary Bladder Neoplasms	2003
Gemcitabine plus vinorelbine chemotherapy in patients with advanced bladder carcinoma who are medically unsuitable for or who have failed cisplatin-based chemotherapy. European urology, 2003, Volume: 44, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Gemcitabine; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prospective Studies; Risk Assessment; Survival Analysis; Terminally Ill; Treatment Failure; Urinary Bladder Neoplasms; Vinblastine; Vinorelbine	2003
Platinum-free combination chemotherapy in patients with advanced or metastatic transitional cell carcinoma. Cancer, 2004, Jan-01, Volume: 100, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Gemcitabine; Humans; Infusions, Intravenous; Male; Methotrexate; Middle Aged; Neutropenia; Paclitaxel; Urologic Neoplasms	2004
Impact of Gemcitabine and Cisplatin with radiotherapy in locally advanced or metastatic transitional cell carcinoma of urinary bladder. JPMA. The Journal of the Pakistan Medical Association, 2003, Volume: 53, Issue:11 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Urinary Bladder Neoplasms	2003
Prospective quality-of-life assessment in patients receiving concurrent gemcitabine and radiotherapy as a bladder preservation strategy. Urology, 2004, Volume: 64, Issue:1 Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystectomy; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Quality of Life; Radiation-Sensitizing Agents; Radiotherapy Planning, Computer-Assisted; Surveys and Questionnaires; Thrombocytopenia; Urinary Bladder Neoplasms	2004
Phase I pharmacokinetic study of a single intravesical instillation of gemcitabine administered immediately after transurethral resection plus multiple random biopsies in patients with superficial bladder cancer. The Journal of urology, 2004, Volume: 172, Issue:2 Topics: Administration, Intravesical; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Cystectomy; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Urinary Bladder Neoplasms	2004
A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer. British journal of cancer, 2004, Aug-31, Volume: 91, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Kidney; Kidney Function Tests; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Outpatients; Treatment Outcome; Urinary Bladder Neoplasms; Viscera	2004
Phase II study to investigate the ablative efficacy of intravesical administration of gemcitabine in intermediate-risk superficial bladder cancer (SBC). European urology, 2004, Volume: 46, Issue:3 Topics: Administration, Intravesical; Aged; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Remission Induction; Treatment Outcome; Urinary Bladder Neoplasms	2004
Gemcitabine and carboplatin combination as first-line treatment in elderly patients and those unfit for cisplatin-based chemotherapy with advanced bladder carcinoma: Phase II study of the Hellenic Co-operative Oncology Group. Urology, 2004, Volume: 64, Issue:3 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma; Carcinoma, Transitional Cell; Cisplatin; Contraindications; Deoxycytidine; Female; Gemcitabine; Hematologic Diseases; Humans; Kidney Function Tests; Life Tables; Male; Neoplasm Metastasis; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms	2004
A 3-week gemcitabine-cisplatin regimen for metastatic urothelial cancer. The Canadian journal of urology, 2004, Volume: 11, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gemcitabine; Humans; Infusions, Intravenous; Male; Middle Aged; Outpatients; Treatment Outcome; Urologic Neoplasms	2004
Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium. Oncology reports, 2005, Volume: 13, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Kidney Neoplasms; Male; Middle Aged; Paclitaxel; Time Factors; Urinary Bladder Neoplasms; Urothelium	2005
Gemcitabine in intravesical treatment of Ta-T1 transitional cell carcinoma of bladder: Phase I-II study on marker lesions. Urology, 2005, Volume: 65, Issue:1 Topics: Administration, Intravesical; Aged; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Deoxycytidine; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prodrugs; Remission Induction; Salvage Therapy; Treatment Outcome; Urinary Bladder Neoplasms	2005
Phase I study of conformal radiotherapy with concurrent gemcitabine in locally advanced bladder cancer. International journal of radiation oncology, biology, physics, 2005, Feb-01, Volume: 61, Issue:2 Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Humans; Male; Maximum Tolerated Dose; Middle Aged; Prospective Studies; Radiation-Sensitizing Agents; Radiotherapy, Conformal; Urinary Bladder Neoplasms	2005
Gemcitabine and docetaxel as first-line treatment for advanced urothelial carcinoma: a phase II study. British journal of cancer, 2005, Feb-28, Volume: 92, Issue:4 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Docetaxel; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Staging; Survival Analysis; Taxoids; Treatment Outcome; Urologic Neoplasms; Urothelium	2005
Weekly paclitaxel and gemcitabine in advanced transitional-cell carcinoma of the urothelium: a phase II Hoosier Oncology Group study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Feb-20, Volume: 23, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Paclitaxel; Thrombocytopenia; Urinary Bladder Neoplasms; Urothelium	2005
A phase II trial of sequential chemotherapy with docetaxel and methotrexate followed by gemcitabine and cisplatin for metastatic urothelial cancer. American journal of clinical oncology, 2005, Volume: 28, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Docetaxel; Drug Administration Schedule; Female; Gemcitabine; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Methotrexate; Middle Aged; Survival Analysis; Taxoids; Urinary Bladder Neoplasms; Urothelium	2005
A nonplatinum combination in metastatic transitional cell carcinoma. American journal of clinical oncology, 2005, Volume: 28, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Gemcitabine; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Middle Aged; Paclitaxel; Survival Analysis; Urinary Bladder Neoplasms	2005
Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium. Cancer, 2005, Jun-01, Volume: 103, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Male; Maximum Tolerated Dose; Middle Aged; Paclitaxel; Treatment Outcome; Urinary Bladder Neoplasms	2005
Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers. European journal of cancer (Oxford, England : 1990), 2005, Volume: 41, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Alkyl and Aryl Transferases; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Disease Progression; Farnesyltranstransferase; Feasibility Studies; Female; Gemcitabine; Humans; Male; Middle Aged; Piperidines; Pyridines; Salvage Therapy; Survival Analysis; Urologic Neoplasms	2005
Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jul-20, Volume: 23, Issue:21 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Disease-Free Survival; Doxorubicin; Female; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Survival Rate; Urinary Bladder Neoplasms; Vinblastine	2005
Randomized phase II marker lesion study evaluating effect of scheduling on response to intravesical gemcitabine in recurrent Stage Ta urothelial cell carcinoma of the bladder. Urology, 2005, Volume: 66, Issue:3 Topics: Administration, Intravesical; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Urinary Bladder Neoplasms	2005
Weekly paclitaxel and gemcitabine in advanced transitional-cell carcinoma of the urothelium: a Phase II Hoosier Oncology Group Study. The Journal of urology, 2005, Volume: 174, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Maximum Tolerated Dose; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Prognosis; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms	2005
Intravesical gemcitabine therapy for superficial transitional cell carcinoma: results of a Phase II prospective multicenter study. Urology, 2005, Volume: 66, Issue:4 Topics: Administration, Intravesical; Aged; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Urinary Bladder Neoplasms	2005
Phase II study of gemcitabine and cisplatin in patients with advanced or metastatic bladder cancer: long-term follow-up of a 3-week regimen. Oncology, 2005, Volume: 69, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Disease Progression; Female; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis; Odds Ratio; Remission Induction; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms	2005
Randomised phase II trial of gemcitabine and paclitaxel second-line chemotherapy in patients with transitional cell carcinoma (AUO Trial AB 20/99). International journal of clinical practice, 2006, Volume: 60, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Disease Progression; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms	2006
A phase I dose finding study of cisplatin, gemcitabine, and weekly docetaxel for patients with advanced transitional cell cancer. American journal of clinical oncology, 2006, Volume: 29, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Infusions, Intravenous; Maximum Tolerated Dose; Middle Aged; Taxoids; Urinary Bladder Neoplasms	2006
Intravesical gemcitabine in BCG-refractory T1G3 transitional cell carcinoma of the bladder: a pilot study. Urologia internationalis, 2006, Volume: 76, Issue:2 Topics: Adjuvants, Immunologic; Administration, Intravesical; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; BCG Vaccine; Carcinoma, Transitional Cell; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Treatment Failure; Urinary Bladder Neoplasms	2006
A phase II monocentric study of oxaliplatin in combination with gemcitabine (GEMOX) in patients with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract. Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:6 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Double-Blind Method; Drug Administration Schedule; Gemcitabine; Humans; Infusions, Intravenous; Organoplatinum Compounds; Oxaliplatin; Pain; Pain Measurement; Placebos; Treatment Outcome; Urologic Neoplasms	2006
Phase I/II study of a combined gemcitabine, etoposide, and cisplatin chemotherapy regimen for metastatic urothelial carcinoma. Cancer, 2006, Jun-01, Volume: 106, Issue:11 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Male; Middle Aged; Survival Rate; Urologic Neoplasms	2006
Phase II trial of intravesical gemcitabine in bacille Calmette-Guérin-refractory transitional cell carcinoma of the bladder. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Jun-20, Volume: 24, Issue:18 Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; BCG Vaccine; Carcinoma, Transitional Cell; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Male; Middle Aged; Remission Induction; Urinary Bladder Neoplasms	2006
Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17 Suppl 5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Disease Progression; Doxorubicin; Female; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Survival Analysis; Time Factors; Urinary Bladder Neoplasms; Vinblastine	2006
A phase II trial of pemetrexed plus gemcitabine in locally advanced and/or metastatic transitional cell carcinoma of the urothelium. Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Gemcitabine; Glutamates; Guanine; Humans; Male; Middle Aged; Neoplasm Metastasis; Pemetrexed; Survival Analysis; Urinary Bladder; Urinary Bladder Neoplasms; Urothelium	2006
[Gemcitabine and carboplatin chemotherapy in advanced transitional cell carcinoma in regard to patients with impaired renal function]. Aktuelle Urologie, 2006, Volume: 37, Issue:5 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Deoxycytidine; Disease Progression; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gemcitabine; Humans; Kidney Failure, Chronic; Kidney Function Tests; Kidney Pelvis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Prospective Studies; Survival Rate; Ureter; Ureteral Neoplasms; Urinary Bladder; Urinary Bladder Neoplasms	2006
Phase II trial of adjuvant gemcitabine plus cisplatin-based chemotherapy in patients with locally advanced bladder cancer. Clinical genitourinary cancer, 2006, Volume: 5, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cyclin-Dependent Kinase Inhibitor p16; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Pilot Projects; Retinoblastoma Protein; Survival Rate; Treatment Outcome; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms	2006
Short-schedule intravesical gemcitabine with ablative intent in recurrent Ta-T1, G1-G2, low- or intermediate-risk, transitional cell carcinoma of the bladder. European urology, 2007, Volume: 51, Issue:4 Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Risk Factors; Urinary Bladder Neoplasms	2007
Chemotherapy with gemcitabine, paclitaxel, and cisplatin in the treatment of patients with advanced transitional cell carcinoma of the urothelium. Oncology reports, 2006, Volume: 16, Issue:6 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms; Urothelium	2006
Docetaxel and gemcitabine combination therapy in advanced transitional cell carcinoma of the urothelium: results of a phase II and pharmacologic study. Anti-cancer drugs, 2007, Volume: 18, Issue:2 Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cell Survival; Deoxycytidine; Docetaxel; Erythrocytes; Female; Gemcitabine; Humans; Male; Middle Aged; Taxoids; Urinary Bladder Neoplasms; Urothelium	2007
Conservative treatment with transurethral resection, neoadjuvant chemotherapy followed by radiochemotherapy in stage T2-3 transitional bladder cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2006, Volume: 8, Issue:12 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Radiotherapy; Urinary Bladder Neoplasms; Urologic Surgical Procedures; Vinblastine	2006
Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium: results of a randomized phase 2 trial. European urology, 2007, Volume: 52, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gemcitabine; Humans; Italy; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome; Turkey; Urinary Bladder Neoplasms; Urothelium	2007
Efficacy and safety of gemcitabine monotherapy in patients with transitional cell carcinoma after Cisplatin-containing therapy: a Japanese experience. Japanese journal of clinical oncology, 2007, Volume: 37, Issue:3 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Urologic Neoplasms; Urothelium	2007
A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium. BMC cancer, 2007, Jun-09, Volume: 7 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Middle Aged; Urinary Bladder Neoplasms; Urothelium	2007
Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:8 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Kidney Function Tests; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Pilot Projects; Urinary Bladder Neoplasms	2007
Gemcitabine plus docetaxel as first-line biweekly therapy in locally advanced and/or metastatic urothelial carcinoma: a phase II study. Anti-cancer drugs, 2007, Volume: 18, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Docetaxel; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis; Taxoids; Treatment Outcome; Urologic Neoplasms; Urothelium	2007
A phase II trial of cisplatin, fixed dose-rate gemcitabine and gefitinib for advanced urothelial tract carcinoma: results of the Cancer and Leukaemia Group B 90102. BJU international, 2008, Volume: 101, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gefitinib; Gemcitabine; Humans; Male; Middle Aged; Quinazolines; Treatment Outcome; Urologic Neoplasms; Urothelium	2008
Activity of endovesical gemcitabine in BCG-refractory bladder cancer patients: a translational study. British journal of cancer, 2007, Dec-03, Volume: 97, Issue:11 Topics: Administration, Intravesical; Aged; Antimetabolites, Antineoplastic; Apoptosis; BCG Vaccine; Carcinoma, Transitional Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxycytidine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Flow Cytometry; Gemcitabine; Humans; Male; Middle Aged; Survival Analysis; Technology Transfer; Urinary Bladder Neoplasms	2007
Phase I study of a 3-drug regimen of gemcitabine/cisplatin/pemetrexed in patients with metastatic transitional cell carcinoma of the urothelium. Investigational new drugs, 2008, Volume: 26, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Dose-Response Relationship, Drug; Female; Folic Acid; Gemcitabine; Glutamates; Guanine; Hematologic Diseases; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Pemetrexed; Treatment Outcome; Urinary Bladder Neoplasms; Urothelium; Vitamin B 12; Vitamin B Complex	2008
Southwest Oncology Group phase II study of irinotecan in patients with advanced transitional cell carcinoma of the urothelium that progressed after platinum-based chemotherapy. Clinical genitourinary cancer, 2008, Volume: 6, Issue:1 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Disease Progression; Female; Gemcitabine; Humans; Irinotecan; Male; Middle Aged; Prospective Studies; Survival Rate; Topoisomerase I Inhibitors; Treatment Outcome; Urologic Neoplasms	2008
Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms	1997
Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:12 Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Deoxycytidine; Female; Gemcitabine; Humans; Kidney Neoplasms; Male; Treatment Outcome; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms	1997
A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. Italian Co-operative Group on Bladder Cancer. European journal of cancer (Oxford, England : 1990), 1998, Volume: 34, Issue:8 Topics: Adult; Aged; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Hematologic Diseases; Humans; Influenza, Human; Infusions, Intravenous; Male; Middle Aged; Treatment Outcome; Urologic Neoplasms	1998
Severe pulmonary toxicity in patients treated with a combination of docetaxel and gemcitabine for metastatic transitional cell carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10, Issue:8 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Docetaxel; Dyspnea; Fatal Outcome; Gemcitabine; Humans; Lung; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Severity of Illness Index; Taxoids; Treatment Outcome; Urinary Bladder Neoplasms	1999
Gemcitabine plus cisplatin, an active regimen in advanced urothelial cancer: a phase II trial of the National Cancer Institute of Canada Clinical Trials Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Kidney Neoplasms; Male; Middle Aged; Thrombocytopenia; Ureteral Neoplasms; Urinary Bladder Neoplasms	1999
Weekly gemcitabine and cisplatin combination therapy in patients with transitional cell carcinoma of the urothelium: a phase II clinical trial. Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Middle Aged; Neutropenia; Survival Analysis; Urologic Neoplasms	1999
Phase I evaluation of sequential doxorubicin gemcitabine then ifosfamide paclitaxel cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:4 Topics: Aged; Agranulocytosis; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Male; Middle Aged; Nausea; Paclitaxel; Remission Induction; Urologic Neoplasms; Vomiting	2000
Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Survival Analysis; Treatment Outcome; Urologic Neoplasms	2000
Gemcitabine plus cisplatin for advanced transitional cell carcinoma of the urinary tract: a phase II multicenter trial. The Journal of urology, 2000, Volume: 164, Issue:1 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Male; Neoplasm Staging; Urologic Neoplasms	2000
Carboplatin-gemcitabine treatment of patients with transitional cell carcinoma of the bladder and impaired renal function. Oncology, 2000, Volume: 59, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Carboplatin; Carcinoma, Transitional Cell; Deoxycytidine; Female; Gemcitabine; Humans; Kidney Diseases; Male; Middle Aged; Survival Analysis; Urinary Bladder Neoplasms	2000
Exploring sequenced chemotherapy regimens in the treatment of transitional cell carcinoma of the urothelial tract. European journal of cancer (Oxford, England : 1990), 2000, Volume: 36 Suppl 2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Cyclophosphamide; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Ifosfamide; Methotrexate; Paclitaxel; Treatment Outcome; Urologic Neoplasms; Vinblastine	2000
A phase II study of gemcitabine plus cisplatin chemotherapy in advanced bilharzial bladder carcinoma. European journal of cancer (Oxford, England : 1990), 2000, Volume: 36 Suppl 2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Schistosomiasis; Treatment Outcome; Urinary Bladder Neoplasms	2000
Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium. Spanish Oncology Genitourinary Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Sep-15, Volume: 18, Issue:18 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Dose Fractionation, Radiation; Gemcitabine; Humans; Male; Middle Aged; Paclitaxel; Survival Analysis; Urologic Neoplasms	2000
Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:17 Topics: Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hospitalization; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Quality of Life; Survival Analysis; Urinary Bladder Neoplasms; Vinblastine	2000
Paclitaxel and gemcitabine chemotherapy for advanced transitional-cell carcinoma of the urothelial tract: a phase II trial of the Minnie pearl cancer research network. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Jun-15, Volume: 19, Issue:12 Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Male; Middle Aged; Paclitaxel; Survival Rate; Urinary Bladder Neoplasms; Urothelium	2001
Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy. Cancer, 2001, Dec-15, Volume: 92, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Gemcitabine; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine	2001
Weekly chemotherapy with docetaxel, gemcitabine and cisplatin in advanced transitional cell urothelial cancer: a phase II trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Male; Middle Aged; Paclitaxel; Taxoids; Urinary Bladder Neoplasms	2002
Gemcitabine monotherapy as second-line treatment in cisplatin-refractory transitional cell carcinoma - prognostic factors for response and improvement of quality of life. Onkologie, 2002, Volume: 25, Issue:1 Topics: Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Follow-Up Studies; Gemcitabine; Humans; Neoplasm Metastasis; Neoplasm Staging; Prospective Studies; Survival Rate; Urinary Bladder Neoplasms	2002
Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Jul-01, Volume: 20, Issue:13 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Drug Administration Schedule; Feasibility Studies; Female; Gemcitabine; Humans; Ifosfamide; Male; Middle Aged; Pilot Projects; Salvage Therapy; Treatment Outcome; Urologic Neoplasms	2002

Other Studies

172 other study(ies) available for gemcitabine and Carcinoma, Transitional Cell

Article	Year
Chronological transition in outcome of second-line treatment in patients with metastatic urothelial cancer after pembrolizumab approval: a multicenter retrospective analysis. International journal of clinical oncology, 2022, Volume: 27, Issue:1 Topics: Aged; Antibodies, Monoclonal, Humanized; Carcinoma, Transitional Cell; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Retrospective Studies; Urinary Bladder Neoplasms	2022
Response to Pembrolizumab After Dose-Reduced Cisplatin Plus Gemcitabine Chemotherapy Is Inferior to That After Carboplatin Plus Gemcitabine Chemotherapy in Cisplatin-Unfit Patients With Advanced Urothelial Carcinoma. Clinical genitourinary cancer, 2022, Volume: 20, Issue:2 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Urinary Bladder Neoplasms	2022
[A Case of Advanced Bladder Carcinoma Treated by Third-Line Gemcitabine and Paclitaxel Chemotherapy]. Hinyokika kiyo. Acta urologica Japonica, 2021, Volume: 67, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Male; Paclitaxel; Urinary Bladder; Urinary Bladder Neoplasms	2021
PD-1 inhibitor toripalimab with gemcitabine as a neoadjuvant therapy for muscle-invasive bladder urothelial carcinoma: A case report. Medicine, 2022, Jan-14, Volume: 101, Issue:2 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cystectomy; Deoxycytidine; Gemcitabine; Humans; Immune Checkpoint Inhibitors; Male; Middle Aged; Muscles; Neoadjuvant Therapy; Treatment Outcome; Urinary Bladder; Urinary Bladder Neoplasms	2022
Sequential Chemotherapy with Gemcitabine and Docetaxel: Breaking the Chains of bacillus Calmette-Guérin. The Journal of urology, 2022, Volume: 208, Issue:3 Topics: Adjuvants, Immunologic; Administration, Intravesical; BCG Vaccine; Carcinoma, Transitional Cell; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Mycobacterium bovis; Urinary Bladder Neoplasms	2022
Are there differences in the characteristics of patients who respond to gemcitabine plus cisplatin chemotherapy and those who respond to pembrolizumab therapy for metastatic urothelial carcinoma? Multicenter retrospective study. International journal of urology : official journal of the Japanese Urological Association, 2022, Volume: 29, Issue:9 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Liver Neoplasms; Retrospective Studies; Urinary Bladder Neoplasms	2022
Comparative analysis of three vs. four cycles of neoadjuvant gemcitabine and cisplatin for muscle invasive bladder cancer. Urologic oncology, 2022, Volume: 40, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Cystectomy; Deoxycytidine; Gemcitabine; Humans; Muscles; Neoadjuvant Therapy; Neoplasm Invasiveness; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms	2022
Re-challenging chemotherapy after pembrolizumab in platinum-refractory urothelial carcinoma. BJU international, 2023, Volume: 131, Issue:4 Topics: Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Methotrexate; Platinum; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine	2023
The efficacy and safety of first-line treatment in cisplatin-ineligible advanced upper tract urothelial carcinoma patients: a comparison of PD-1 inhibitor and carboplatin plus gemcitabine chemotherapy. Oncoimmunology, 2022, Volume: 11, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Immune Checkpoint Inhibitors; Retrospective Studies; Urinary Bladder Neoplasms	2022
Remarkable response to gemcitabine rechallenge in advanced urothelial carcinoma: a case report. Anti-cancer drugs, 2022, 11-01, Volume: 33, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Gemcitabine; Humans; Male; Urinary Bladder Neoplasms	2022
Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder. Cancer research and treatment, 2023, Volume: 55, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Muscles; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nivolumab; Prospective Studies; Urinary Bladder; Urinary Bladder Neoplasms	2023
Allyl-, Butyl- and Phenylethyl-Isothiocyanate Modulate Akt-mTOR and Cyclin-CDK Signaling in Gemcitabine- and Cisplatin-Resistant Bladder Cancer Cell Lines. International journal of molecular sciences, 2022, Sep-20, Volume: 23, Issue:19 Topics: Apoptosis; Carcinoma, Transitional Cell; Cell Line, Tumor; Cisplatin; Cyclin-Dependent Kinases; Cyclins; Deoxycytidine; Gemcitabine; Humans; Isothiocyanates; Proto-Oncogene Proteins c-akt; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Urinary Bladder Neoplasms	2022
Gemcitabine-Paclitaxel Chemotherapy for Patients with Advanced Urothelial Cancer Refractory to Cisplatin-Based Chemotherapy: Predictive Role of PGK1 for Treatment Response to Cytotoxic Chemotherapy. International journal of molecular sciences, 2022, Oct-11, Volume: 23, Issue:20 Topics: Antineoplastic Combined Chemotherapy Protocols; Biological Products; Carcinoma, Transitional Cell; Cisplatin; Gemcitabine; Humans; Immune Checkpoint Inhibitors; Paclitaxel; Phosphoglycerate Kinase; Platinum; Retrospective Studies	2022
Comparison of full-dose gemcitabine/cisplatin, dose-reduced gemcitabine/cisplatin, and gemcitabine/carboplatin in real-world patients with advanced urothelial carcinoma. BMC urology, 2022, Nov-09, Volume: 22, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Gemcitabine; Humans; Retrospective Studies; Urinary Bladder Neoplasms	2022
Probiotics enhances anti-tumor immune response induced by gemcitabine plus cisplatin chemotherapy for urothelial cancer. Cancer science, 2023, Volume: 114, Issue:3 Topics: Animals; Carcinoma, Transitional Cell; CD8-Positive T-Lymphocytes; Cisplatin; Gemcitabine; Immunity; Mice; Mice, Inbred C3H; Probiotics; Tumor Microenvironment; Urinary Bladder Neoplasms	2023
IDH2 stabilizes HIF-1α-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer. The EMBO journal, 2023, 02-15, Volume: 42, Issue:4 Topics: Carcinoma, Transitional Cell; Cell Line, Tumor; Drug Resistance, Neoplasm; Gemcitabine; Glycolysis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Pentose Phosphate Pathway; Urinary Bladder Neoplasms	2023
[TREATMENT OF BLADDER UROTHELIAL CARCINOMA WITH LUNG METASTASIS AFTER RENAL TRANSPLANTATION]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2022, Volume: 113, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Cystectomy; Female; Gemcitabine; Humans; Kidney Transplantation; Lung Neoplasms; Middle Aged; Urinary Bladder; Urinary Bladder Neoplasms	2022
Gemcitabine-cisplatin versus MVAC chemotherapy for urothelial carcinoma: a nationwide cohort study. Scientific reports, 2023, 03-06, Volume: 13, Issue:1 Topics: Carcinoma, Transitional Cell; Cisplatin; Cohort Studies; Doxorubicin; Gemcitabine; Granulocyte Colony-Stimulating Factor; Humans; Methotrexate; Urinary Bladder Neoplasms; Vinblastine	2023
Real-world outcomes of first-line chemotherapy for unresectable stage III and IV bladder cancer. World journal of urology, 2023, Volume: 41, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Treatment Outcome; Urinary Bladder Neoplasms	2023
Real-world retrospective review of monotherapy following platinum-based chemotherapy for metastatic urothelial cancer. The Journal of international medical research, 2023, Volume: 51, Issue:5 Topics: Carcinoma, Transitional Cell; Drug Therapy, Combination; Gemcitabine; Humans; Retrospective Studies; Urinary Bladder Neoplasms	2023
Kidney and Cancer Outcomes with Standard Versus Alternative Chemotherapy Regimens for First-Line Treatment of Metastatic Urothelial Carcinoma. Kidney360, 2023, 09-01, Volume: 4, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Female; Gemcitabine; Humans; Kidney; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms	2023
Flashback Foreword: Gemcitabine/Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Transitional Cell Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023, 08-10, Volume: 41, Issue:23 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Methotrexate; Urinary Bladder Neoplasms; Vinblastine	2023
Cost-effectiveness of Pembrolizumab for Patients with Advanced, Unresectable, or Metastatic Urothelial Cancer Ineligible for Cisplatin-based Therapy. European urology oncology, 2019, Volume: 2, Issue:5 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Computer Simulation; Cost-Benefit Analysis; Deoxycytidine; Drug Costs; Gemcitabine; Humans; Models, Economic; Progression-Free Survival; Quality-Adjusted Life Years; Sweden; Urologic Neoplasms	2019
Sarcopenia as a significant predictive factor of neutropenia and overall survival in urothelial carcinoma patients underwent gemcitabine and cisplatin or carboplatin. International journal of clinical oncology, 2020, Volume: 25, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Cystectomy; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Neutropenia; Retrospective Studies; Sarcopenia; Thrombocytopenia; Tomography, X-Ray Computed; Urologic Neoplasms	2020
Metabolomic profiling identifies novel biomarkers and mechanisms in human bladder cancer treated with submucosal injection of gemcitabine. International journal of molecular medicine, 2019, Volume: 44, Issue:5 Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Transitional Cell; Deoxycytidine; Female; Gemcitabine; Humans; Male; Metabolic Networks and Pathways; Metabolome; Metabolomics; Middle Aged; Neoplasm Recurrence, Local; Principal Component Analysis; Urinary Bladder; Urinary Bladder Neoplasms	2019
Skeletal Muscle Mass Reduction Velocity as a Simple Prognostic Indicator for Patients with Metastatic Urothelial Carcinoma Receiving Second-Line Chemotherapy. Asian Pacific journal of cancer prevention : APJCP, 2019, Oct-01, Volume: 20, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Docetaxel; Female; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Muscle, Skeletal; Prognosis; Retrospective Studies; Sarcopenia; Survival Rate; Urologic Neoplasms	2019
Is it time to redefine cisplatin ineligibility in metastatic urothelial cancer? European journal of cancer (Oxford, England : 1990), 2020, Volume: 127 Topics: Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Urologic Neoplasms; Vinblastine	2020
Downstaging of Muscle-Invasive Bladder Cancer Using Neoadjuvant Gemcitabine and Cisplatin or Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin as Single Regimens or as Switch Therapy Modalities. Clinical genitourinary cancer, 2020, Volume: 18, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Cystectomy; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Methotrexate; Muscles; Neoadjuvant Therapy; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine	2020
Recurrent Bladder Cancer in a Teenage Male. Urology, 2020, Volume: 141 Topics: Adjuvants, Immunologic; Administration, Intravesical; Adolescent; Antimetabolites, Antineoplastic; BCG Vaccine; Carcinoma, Transitional Cell; Cystectomy; Cystoscopy; Deoxycytidine; Gemcitabine; Humans; Male; Monitoring, Physiologic; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Treatment Outcome; Urinary Bladder Neoplasms	2020
Compensatory combination of romidepsin with gemcitabine and cisplatin to effectively and safely control urothelial carcinoma. British journal of cancer, 2020, Volume: 123, Issue:2 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Deoxycytidine; Depsipeptides; Gemcitabine; Humans; MAP Kinase Signaling System; Mice; Neoplasm Recurrence, Local; Reactive Oxygen Species; Urinary Bladder Neoplasms; Urothelium; Xenograft Model Antitumor Assays	2020
Two cycles of neoadjuvant chemotherapy improves survival in patients with high-risk upper tract urothelial carcinoma. BJU international, 2021, Volume: 127, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Kidney Neoplasms; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Nephroureterectomy; Proportional Hazards Models; Retrospective Studies; Sex Factors; Survival Rate; Ureteral Neoplasms; Vinblastine	2021
Right supernumerary kidney with urothelial carcinoma: A case report. Medicine, 2020, Sep-18, Volume: 99, Issue:38 Topics: Aged; Antineoplastic Agents; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Kidney; Kidney Neoplasms; Nephroureterectomy; Ureter	2020
Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma. BJU international, 2021, Volume: 127, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Comparative Effectiveness Research; Cystectomy; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Kidney Neoplasms; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Nephroureterectomy; Proportional Hazards Models; Retrospective Studies; Survival Rate; Treatment Outcome; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine	2021
Perioperative Treatment in Muscle-invasive Bladder Cancer: Analysis of Secondary Endpoints in a Randomized Trial Comparing Gemcitabine and Cisplatin Versus Dose-dense Methotrexate, Vinblastine, Adriamycin, and Cisplatin. European urology, 2021, Volume: 79, Issue:2 Topics: Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Methotrexate; Muscles; Urinary Bladder Neoplasms; Vinblastine	2021
Combination of novel intravesical xenogeneic urothelial cell immunotherapy and chemotherapy enhances anti-tumor efficacy in preclinical murine bladder tumor models. Cancer immunology, immunotherapy : CII, 2021, Volume: 70, Issue:5 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cell- and Tissue-Based Therapy; Cisplatin; Deoxycytidine; Epithelial Cells; Gemcitabine; Humans; Immunotherapy; Lymphocyte Activation; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Microspheres; Swine; T-Lymphocytes; Transplantation, Heterologous; Tumor Burden; Urinary Bladder Neoplasms; Urothelium	2021
[Fever after Gemcitabine Administration is a Poor Prognostic Factor in Patients with Metastatic Urothelial Carcinoma : Multicenter Retrospective Study]. Hinyokika kiyo. Acta urologica Japonica, 2021, Volume: 67, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Prognosis; Retrospective Studies; Treatment Outcome	2021
Combination therapy with paclitaxel and gemcitabine after platinum-based chemotherapy in patients with advanced urothelial cancer. International journal of urology : official journal of the Japanese Urological Association, 2021, Volume: 28, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Paclitaxel; Platinum; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms	2021
Editorial Comment to Combination therapy with paclitaxel and gemcitabine after platinum-based chemotherapy in patients with advanced urothelial cancer. International journal of urology : official journal of the Japanese Urological Association, 2021, Volume: 28, Issue:9 Topics: Carcinoma, Transitional Cell; Deoxycytidine; Gemcitabine; Humans; Paclitaxel; Platinum	2021
Comparison of Efficacy of Adjuvant MEC (Methotrexate, Epirubicin and Cisplatin) and GC (Gemcitabine and Cisplatin) in Advanced Upper Tract Urothelial Carcinoma. Anticancer research, 2017, Volume: 37, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Risk Factors; Survival Rate; Urologic Neoplasms	2017
The impact of a solitary kidney on tolerability to gemcitabine plus cisplatin chemotherapy in urothelial carcinoma patients: a retrospective study. Cancer chemotherapy and pharmacology, 2017, Volume: 79, Issue:5 Topics: Acute Kidney Injury; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Kidney; Male; Middle Aged; Nephrectomy; Neutropenia; Retrospective Studies; Urinary Bladder Neoplasms	2017
The renal safety and efficacy of combined gemcitabine plus cisplatin and gemcitabine plus carboplatin chemotherapy in Chinese patients with a solitary kidney after nephroureterectomy. Cancer chemotherapy and pharmacology, 2017, Volume: 80, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asian People; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Creatinine; Deoxycytidine; Female; Gemcitabine; Glomerular Filtration Rate; Humans; Kidney; Kidney Neoplasms; Male; Middle Aged; Nephrectomy; Retrospective Studies; Risk Factors; Ureteral Neoplasms	2017
Gemcitabine/Cisplatin Treatment Induces Concomitant SERTAD1, CDKN2B and GADD45A Modulation and Cellular Changes in Bladder Cancer Cells Regardless of the Site of TP53 Mutation. Pathology oncology research : POR, 2018, Volume: 24, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Transitional Cell; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cisplatin; Cyclin-Dependent Kinase Inhibitor p15; Deoxycytidine; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Mutation; Nuclear Proteins; Trans-Activators; Transcription Factors; Tumor Suppressor Protein p53; Up-Regulation; Urinary Bladder Neoplasms	2018
Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma. European urology focus, 2018, Volume: 4, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Kidney Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Staging; Nephrectomy; Prognosis; Progression-Free Survival; Proportional Hazards Models; Retrospective Studies; Survival Rate; Ureter; Ureteral Neoplasms; Urologic Surgical Procedures	2018
Bladder Urothelial Carcinoma with Peritoneal Involvement: Benefit of Continuous Maintenance Chemotherapy. Anticancer research, 2017, Volume: 37, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemoradiotherapy; Cisplatin; Cystectomy; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Humans; Leucovorin; Maintenance Chemotherapy; Male; Middle Aged; Peritoneal Neoplasms; Retrospective Studies; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms	2017
Neoadjuvant Chemotherapy for Patients with Muscle-invasive Urothelial Bladder Cancer Candidates for Curative Surgery: A Prospective Clinical Trial Based on Cisplatin Feasibility. Anticancer research, 2017, Volume: 37, Issue:11 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Cystectomy; Deoxycytidine; Disease-Free Survival; Feasibility Studies; Female; Gemcitabine; Humans; Male; Middle Aged; Neoadjuvant Therapy; Prospective Studies; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms	2017
Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma. The Journal of urology, 2018, Volume: 200, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Nephroureterectomy; Retrospective Studies; Ureter; Ureteral Neoplasms	2018
Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical Cystectomy. The Journal of urology, 2018, Volume: 199, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Cystectomy; Deoxycytidine; Doxorubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Retrospective Studies; Survival Rate; Treatment Outcome; Urinary Bladder; Urinary Bladder Neoplasms; Vinblastine	2018
Factors that Predict Neutropenia in Korean Patients with Advanced Urothelial Cancer after Cisplatin- Based Systemic Chemotherapy. Urology journal, 2018, 07-10, Volume: 15, Issue:4 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Leukocyte Count; Methotrexate; Middle Aged; Neutropenia; Neutrophils; Republic of Korea; Risk Factors; Urologic Neoplasms; Vinblastine	2018
Salvage topical therapy for upper tract urothelial carcinoma. World journal of urology, 2018, Volume: 36, Issue:12 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Antineoplastic Agents; BCG Vaccine; Carcinoma in Situ; Carcinoma, Transitional Cell; Deoxycytidine; Female; Gemcitabine; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Mitomycin; Nephrostomy, Percutaneous; Retrospective Studies; Salvage Therapy; Treatment Outcome; Ureteral Neoplasms; Urinary Catheterization	2018
Long term oncologic outcome in patients with bladder cancer after radical cystectomy: Impact of carcinoma in situ in the era of neoadjuvant chemotherapy. International urology and nephrology, 2019, Volume: 51, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Deoxycytidine; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Neoplasms, Multiple Primary; Survival Rate; Time Factors; Urinary Bladder Neoplasms; Vinblastine	2019
Impact of adjuvant chemotherapy on oncologic outcomes following radical nephroureterectomy for patients with pT3NanyM0 upper tract urothelial carcinoma: A retrospective cohort study. International journal of surgery (London, England), 2019, Volume: 66 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Nephroureterectomy; Proportional Hazards Models; Retrospective Studies; Urologic Neoplasms	2019
Second-line systemic therapies for metastatic urothelial carcinoma: a population-based cohort analysis. Current oncology (Toronto, Ont.), 2019, Volume: 26, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Male; Middle Aged; Paclitaxel; Treatment Outcome; Urologic Neoplasms; Urothelium	2019
Neoadjuvant chemotherapy improves survival rate in advanced urothelial carcinoma. The Kaohsiung journal of medical sciences, 2013, Volume: 29, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms; Urothelium	2013
Concurrent chemoradiotherapy with low dose weekly gemcitabine in medically inoperable muscle-invasive bladder cancer patients. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2014, Volume: 16, Issue:1 Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Chemoradiotherapy; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms	2014
The method of GFR determination impacts the estimation of cisplatin eligibility in patients with advanced urothelial cancer. World journal of urology, 2014, Volume: 32, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Cohort Studies; Creatinine; Deoxycytidine; Female; Gemcitabine; Glomerular Filtration Rate; Humans; Linear Models; Male; Patient Selection; Renal Insufficiency; Retrospective Studies	2014
The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer. World journal of urology, 2014, Volume: 32, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Cystectomy; Deoxycytidine; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Muscle, Smooth; Neoadjuvant Therapy; Neoplasm Invasiveness; Proportional Hazards Models; Retrospective Studies; Smoking; Treatment Outcome; Urinary Bladder; Urinary Bladder Neoplasms	2014
Expression of nucleoside transporters and deoxycytidine kinase proteins in muscle invasive urothelial carcinoma of the bladder: correlation with pathological response to neoadjuvant platinum/gemcitabine combination chemotherapy. The Journal of urology, 2014, Volume: 191, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Deoxycytidine Kinase; Female; Gemcitabine; Humans; Male; Middle Aged; Muscle, Smooth; Neoadjuvant Therapy; Neoplasm Invasiveness; Nucleoside Transport Proteins; Platinum Compounds; Predictive Value of Tests; Urinary Bladder Neoplasms	2014
Regression of choroidal neovascularization in response to systemic chemotherapy for cancer. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2013, Volume: 48, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Choroidal Neovascularization; Cisplatin; Deoxycytidine; Docetaxel; Fatal Outcome; Fluorescein Angiography; Gemcitabine; Humans; Male; Remission Induction; Taxoids; Tomography, Optical Coherence; Urethral Neoplasms; Urinary Bladder Neoplasms	2013
The effect of photochemical internalization of bleomycin in the treatment of urothelial carcinoma of the bladder: an in vitro study. Urologic oncology, 2014, Volume: 32, Issue:1 Topics: Animals; Antibiotics, Antineoplastic; Bleomycin; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Epirubicin; Gemcitabine; Humans; Light; Mitomycin; Photochemotherapy; Photosensitizing Agents; Porphyrins; Rats; Time Factors; Urinary Bladder Neoplasms	2014
No relationship between the amount of DNA damage and the level of hMLH1 and RASSF1A gene expression in bladder cancer cells treated with cisplatin and gemcitabine. Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:10 Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Transitional Cell; Cisplatin; Comet Assay; Deoxycytidine; DNA Damage; DNA Methylation; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; MutL Protein Homolog 1; Nuclear Proteins; Promoter Regions, Genetic; Real-Time Polymerase Chain Reaction; Tumor Cells, Cultured; Tumor Suppressor Proteins; Urinary Bladder Neoplasms	2013
Therapeutic potential of sepantronium bromide YM155 in gemcitabine-resistant human urothelial carcinoma cells. Oncology reports, 2014, Volume: 31, Issue:2 Topics: Adenine; Antimetabolites, Antineoplastic; Apoptosis; Autophagy; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p27; Deoxycytidine; DNA Fragmentation; Drug Resistance, Neoplasm; Everolimus; Gemcitabine; Humans; Imidazoles; Inhibitor of Apoptosis Proteins; Ki-67 Antigen; Microtubule-Associated Proteins; Naphthoquinones; Proto-Oncogene Proteins c-bcl-2; Securin; Sirolimus; Survivin; TOR Serine-Threonine Kinases; Urinary Bladder Neoplasms; Urothelium	2014
Hypofractionated intensity modulated radiation therapy in combined modality treatment for bladder preservation in elderly patients with invasive bladder cancer. International journal of radiation oncology, biology, physics, 2014, Feb-01, Volume: 88, Issue:2 Topics: Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Humans; Male; Organ Sparing Treatments; Radiation-Sensitizing Agents; Radiotherapy, Intensity-Modulated; Retrospective Studies; Treatment Outcome; Urinary Bladder; Urinary Bladder Neoplasms	2014
[Treatment and prognosis of 117 patients with advanced urothelial carcinoma of the bladder]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2014, Volume: 36, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Cyclophosphamide; Deoxycytidine; Disease-Free Survival; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Retrospective Studies; Survival Rate; Thrombocytopenia; Urinary Bladder Neoplasms; Urothelium	2014
Involvement of p38 mitogen-activated protein kinase in acquired gemcitabine-resistant human urothelial carcinoma sublines. The Kaohsiung journal of medical sciences, 2014, Volume: 30, Issue:7 Topics: Antimetabolites, Antineoplastic; Apoptosis; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Survival; Deoxycytidine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Flavonoids; Gemcitabine; Humans; Imidazoles; p38 Mitogen-Activated Protein Kinases; Pyridines; Urinary Bladder Neoplasms	2014
[Toxicity of intravesical gemcitabine in superficial bladder cancer treatment]. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2014, May-01, Volume: 38, Issue:3 Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Deoxycytidine; Gemcitabine; Humans; Male; Middle Aged; Treatment Outcome; Urinary Bladder Neoplasms	2014
Low-dose maintenance gemcitabine-carboplatin chemotherapy could be an alternative to continuous standard chemotherapy for patients with metastatic urothelial carcinoma. International journal of urology : official journal of the Japanese Urological Association, 2014, Volume: 21, Issue:11 Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Retrospective Studies; Urologic Neoplasms	2014
Oncological outcomes of advanced muscle-invasive bladder cancer with a micropapillary variant after radical cystectomy and adjuvant platinum-based chemotherapy. World journal of urology, 2015, Volume: 33, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Papillary; Carcinoma, Transitional Cell; Case-Control Studies; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Cystectomy; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Lymph Node Excision; Lymph Nodes; Male; Methotrexate; Middle Aged; Multivariate Analysis; Muscle, Smooth; Neoplasm Staging; Proportional Hazards Models; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine	2015
The first Slovak experience with second-line vinflunine in advanced urothelial carcinomas. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2014, Volume: 27, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Prognosis; Slovakia; Survival Analysis; Treatment Outcome; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine	2014
Clinical outcomes following neoadjuvant cisplatin-based chemotherapy for bladder cancer in elderly compared with younger patients. European journal of cancer care, 2015, Volume: 24, Issue:2 Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Male; Middle Aged; Neoadjuvant Therapy; Patient Selection; Retrospective Studies; Survival Analysis; Urinary Bladder Neoplasms	2015
Successful treatment of metastatic urothelial carcinoma arising in a transplanted renal allograft with paclitaxel, cisplatin, and gemcitabine combination therapy: a case report. BMC research notes, 2015, Feb-04, Volume: 8 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Gemcitabine; Hematuria; Humans; Kidney Transplantation; Lung Neoplasms; Male; Paclitaxel; Treatment Outcome; Urinary Bladder Neoplasms; Urothelium	2015
Bevacizumab combined with chemotherapy in the treatment of recurrence or platinum-refractory ovarian cancer: a retrospective study of 37 cases. Indian journal of cancer, 2014, Volume: 51 Suppl 3 Topics: Adenocarcinoma, Papillary; Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Transitional Cell; Cystadenocarcinoma, Serous; Deoxycytidine; Drug Resistance, Neoplasm; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prognosis; Retrospective Studies; Survival Rate	2014
Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer. Cancer, 2015, Aug-01, Volume: 121, Issue:15 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Muscle Neoplasms; Neoadjuvant Therapy; Neoplasm Invasiveness; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine	2015
Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:8 Topics: Adenocarcinoma; Aged; Albumin-Bound Paclitaxel; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Gemcitabine; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Mitomycin; Neoadjuvant Therapy; Paclitaxel; Perioperative Care; Retrospective Studies; Urethra; Urethral Neoplasms; Urinary Diversion	2015
Sequential chemotherapy using gemcitabine + carboplatin followed by gemcitabine + carboplatin + docetaxel for advanced upper-tract urothelial cancer. International journal of clinical oncology, 2015, Volume: 20, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Creatinine; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Male; Middle Aged; Retrospective Studies; Survival Rate; Taxoids; Treatment Outcome; Urologic Neoplasms	2015
Impact of renal function of patients with advanced urothelial cancer on eligibility for first-line chemotherapy and treatment outcomes. Japanese journal of clinical oncology, 2015, Volume: 45, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Cohort Studies; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Glomerular Filtration Rate; Humans; Male; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine	2015
Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy-induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients. International journal of urology : official journal of the Japanese Urological Association, 2015, Volume: 22, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Dexamethasone; Drug Therapy, Combination; Female; Gemcitabine; Granisetron; Humans; Isoquinolines; Kidney Neoplasms; Male; Middle Aged; Morpholines; Nausea; Ondansetron; Palonosetron; Quinuclidines; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vomiting	2015
Neoadjuvant induction dose-dense MVAC for muscle invasive bladder cancer: efficacy and safety compared with classic MVAC and gemcitabine/cisplatin. World journal of urology, 2016, Volume: 34, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Retrospective Studies; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine	2016
Changing trends in utilization of neoadjuvant chemotherapy in muscle-invasive bladder cancer. The Canadian journal of urology, 2015, Volume: 22, Issue:4 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Vessels; Carboplatin; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Glomerular Filtration Rate; Humans; Lymphatic Metastasis; Lymphatic Vessels; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Renal Insufficiency, Chronic; Retrospective Studies; Survival Rate; Treatment Outcome; Urinary Bladder Neoplasms	2015
An Effective and Well Tolerated Strategy of Bladder Preservation Therapy in Cisplatin-Ineligible Patients With Muscle-Invasive Bladder Cancer. Clinical genitourinary cancer, 2016, Volume: 14, Issue:1 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Chemoradiotherapy; Cisplatin; Cystectomy; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Invasiveness; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms	2016
Tolerability of Gemcitabine Plus Cisplatin for Treatment of Urothelial Cancer in the Elderly Population. Clinical genitourinary cancer, 2016, Volume: 14, Issue:3 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Male; Neoadjuvant Therapy; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms	2016
Metastatic cardiac tumor from urothelial carcinoma detected by transthoracic echocardiography: a case report. Journal of medical case reports, 2015, Nov-16, Volume: 9 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Echocardiography; Fatal Outcome; Gemcitabine; Heart Neoplasms; Humans; Male; Multiple Organ Failure; Paclitaxel; Tomography, X-Ray Computed; Treatment Outcome; Urothelium	2015
The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents. Cancer, 2016, Mar-01, Volume: 122, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Transitional Cell; Case-Control Studies; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Incidence; Kidney Neoplasms; Kidney Pelvis; Logistic Models; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Retrospective Studies; Stroke; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Venous Thromboembolism	2016
Do metastatic upper tract urothelial carcinoma and bladder carcinoma have similar clinical responses to systemic chemotherapy? A Japanese multi-institutional experience. Japanese journal of clinical oncology, 2016, Volume: 46, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine	2016
Gemcitabine and mitomycin induced autophagy regulates cancer stem cell pool in urothelial carcinoma cells. Biochimica et biophysica acta, 2016, Volume: 1863, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Autophagy; Autophagy-Related Protein 7; Blotting, Western; Carcinoma, Transitional Cell; Deoxycytidine; Drug Resistance, Neoplasm; Female; Flow Cytometry; Gemcitabine; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Male; Middle Aged; Mitomycin; Neoplastic Stem Cells; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Tumor Cells, Cultured; Ubiquitin-Activating Enzymes; Urinary Bladder Neoplasms; Young Adult	2016
Singapore Cancer Network (SCAN) Guidelines for Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer. Annals of the Academy of Medicine, Singapore, 2015, Volume: 44, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Methotrexate; Muscle, Smooth; Neoadjuvant Therapy; Neoplasm Invasiveness; Singapore; Urinary Bladder Neoplasms; Vinblastine	2015
Complete and Durable Remission of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Urothelial Carcinoma Following Third-Line Treatment with Trastuzumab and Gemcitabine. Urologia internationalis, 2018, Volume: 100, Issue:1 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Gemcitabine; Humans; Receptor, ErbB-2; Remission Induction; Trastuzumab	2018
A Case of Gemcitabine and Cisplatin Chemotherapy in a Patient With Metastatic Urothelial Carcinoma Receiving Hemodialysis. Clinical genitourinary cancer, 2016, Volume: 14, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Male; Renal Dialysis; Urologic Neoplasms	2016
Invasive urothelial carcinoma, lymphoma-like/plasmacytoid variant, successfully treated by radical cystectomy with adjuvant chemotherapy: a case report. Journal of medical case reports, 2016, Mar-08, Volume: 10 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Deoxycytidine; Gemcitabine; Humans; Male; Neoplasm Invasiveness; Urinary Bladder Neoplasms	2016
Neoadjuvant chemotherapy in urothelial bladder cancer: impact of regimen and variant histology. Future oncology (London, England), 2016, Volume: 12, Issue:15 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Cystectomy; Deoxycytidine; Disease-Free Survival; Doxorubicin; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Proportional Hazards Models; Retrospective Studies; Urinary Bladder Neoplasms; Vinblastine	2016
Current status of systemic chemotherapy for octogenarians with advanced urothelial cancer in Japan: a Japanese multi-institutional study (CURE study). International journal of clinical oncology, 2016, Volume: 21, Issue:6 Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Drug Monitoring; Female; Gemcitabine; Humans; Japan; Kidney Function Tests; Male; Medication Therapy Management; Methotrexate; Retrospective Studies; Survival Rate; Urologic Neoplasms; Urothelium; Vinblastine	2016
Re: Vinflunine-gemcitabine Versus Vinflunine-carboplatin as First-line Chemotherapy in Cisplatin-unfit Patients with Advanced Urothelial Carcinoma: Results of an International Randomized Phase II Trial (JASINT1). European urology, 2016, Volume: 70, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Treatment Outcome; Vinblastine	2016
Evidence of a clinically significant interaction between warfarin and intravesical gemcitabine. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2016, Oct-01, Volume: 73, Issue:19 Topics: Administration, Intravesical; Aged, 80 and over; Anticoagulants; Antimetabolites, Antineoplastic; BCG Vaccine; Carcinoma, Transitional Cell; Deoxycytidine; Drug Interactions; Enoxaparin; Gemcitabine; Humans; International Normalized Ratio; Male; Urinary Bladder Neoplasms; Venous Thrombosis; Warfarin	2016
Prolonged Remission of Upper Urinary Tract Urothelial Carcinoma With Prominent Choriocarcinomatous Differentiation: A Case Report. Clinical genitourinary cancer, 2017, Volume: 15, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Transitional Cell; Choriocarcinoma; Cisplatin; Cyclophosphamide; Dactinomycin; Deoxycytidine; Doxorubicin; Etoposide; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pelvic Neoplasms; Remission Induction; Ureteral Neoplasms	2017
Gemcitabine-induced hemolytic-uremic syndrome treated with eculizumab or plasmapheresis: two case reports . Clinical nephrology, 2017, Volume: 87 (2017), Issue:2 Topics: Acute Kidney Injury; Adenocarcinoma; Aged; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Kidney Function Tests; Male; Pancreatic Neoplasms; Plasmapheresis; Purpura, Thrombotic Thrombocytopenic; Renal Dialysis; Treatment Outcome	2017
A SPATIOTEMPORAL MODEL TO SIMULATE CHEMOTHERAPY REGIMENS FOR HETEROGENEOUS BLADDER CANCER METASTASES TO THE LUNG. Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing, 2017, Volume: 22 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cell Line, Tumor; Cisplatin; Computational Biology; Computer Simulation; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Humans; Lung Neoplasms; Models, Biological; Urinary Bladder Neoplasms	2017
Quality-of-life evaluation during platinum-based neoadjuvant chemotherapies for urothelial carcinoma. International journal of clinical oncology, 2017, Volume: 22, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Prospective Studies; Quality of Life; Urologic Neoplasms	2017
Venous thromboembolism in metastatic urothelial carcinoma or variant histologies: incidence, associative factors, and effect on survival. Cancer medicine, 2017, Volume: 6, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Incidence; Male; Middle Aged; Neoplasm Metastasis; Prognosis; Retrospective Studies; Survival Analysis; Urinary Bladder Neoplasms; Venous Thromboembolism	2017
Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine. Journal of experimental & clinical cancer research : CR, 2017, 01-03, Volume: 36, Issue:1 Topics: Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Caspases; Cell Cycle; Cell Line, Tumor; Cell Survival; Checkpoint Kinase 1; Checkpoint Kinase 2; Deoxycytidine; DNA Damage; Drug Screening Assays, Antitumor; Drug Synergism; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Poly(ADP-ribose) Polymerases; Protein Kinase Inhibitors; RNA, Small Interfering; Thiophenes; Urea; Urinary Bladder Neoplasms	2017
The marine triterpene glycoside frondoside A induces p53-independent apoptosis and inhibits autophagy in urothelial carcinoma cells. BMC cancer, 2017, 02-01, Volume: 17, Issue:1 Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Survival; Cisplatin; Deoxycytidine; Drug Screening Assays, Antitumor; Drug Synergism; Gemcitabine; Glycosides; Humans; Sea Cucumbers; Triterpenes; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms	2017
Cytidine Deaminase Activity Assessment to Select Perioperative Chemotherapy Regimen in Localized Bladder Cancer. Clinical genitourinary cancer, 2017, Volume: 15, Issue:3 Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cytidine Deaminase; Deoxycytidine; Gemcitabine; Humans; Male; Urinary Bladder Neoplasms	2017
Difference in toxicity reporting between patients and clinicians during systemic chemotherapy in patients with urothelial carcinoma. International journal of urology : official journal of the Japanese Urological Association, 2017, Volume: 24, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Constipation; Deoxycytidine; Diarrhea; Feeding and Eating Disorders; Female; Gemcitabine; Humans; Male; Nausea; Patient Reported Outcome Measures; Prospective Studies; Quality of Life; Retrospective Studies; Treatment Outcome; Urologic Neoplasms	2017
A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience. Cancer, 2008, Nov-01, Volume: 113, Issue:9 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Deoxycytidine; Disease-Free Survival; Feasibility Studies; Female; Gemcitabine; Humans; Male; Middle Aged; Muscle Neoplasms; Neoadjuvant Therapy; Neoplasm Invasiveness; Retrospective Studies; Survival Rate; Urinary Bladder Neoplasms	2008
[Combination therapy consisting of gemcitabine, docetaxel and carboplatin as a second-line chemotherapy for patients with MVAC-treated metastatic urothelial carcinoma]. Hinyokika kiyo. Acta urologica Japonica, 2008, Volume: 54, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Disease-Free Survival; Docetaxel; Doxorubicin; Drug Administration Schedule; Gemcitabine; Hematologic Diseases; Humans; Methotrexate; Neoplasm Metastasis; Retrospective Studies; Taxoids; Urologic Neoplasms; Vinblastine	2008
Adjuvant chemotherapy for locally advanced urothelial carcinoma: an overview of the USC experience. World journal of urology, 2009, Volume: 27, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; California; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Disease Progression; Doxorubicin; Feasibility Studies; Female; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Retrospective Studies; Universities; Urinary Bladder Neoplasms; Vinblastine	2009
[Metastases from urethelial carcinoma: role of chemotherapy]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2008, Volume: 18 Suppl 7 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Methotrexate; Urinary Bladder Neoplasms; Vinblastine	2008
Gemcitabine and paclitaxel chemotherapy for advanced urothelial carcinoma in patients who have received prior cisplatin-based chemotherapy. International journal of clinical oncology, 2008, Volume: 13, Issue:6 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Feasibility Studies; Female; Gemcitabine; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Paclitaxel; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Urinary Bladder Neoplasms	2008
Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: a contemporary series. Cancer, 2009, Feb-15, Volume: 115, Issue:4 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Combined Modality Therapy; Cystectomy; Deoxycytidine; Doxorubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Male; Maximum Tolerated Dose; Methotrexate; Middle Aged; Muscle Neoplasms; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Risk Factors; Survival Rate; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine	2009
Palliative chemotherapy with gemcitabine, paclitaxel, and cisplatin as first-line treatment following gemcitabine monotherapy for patients with transitional cell carcinoma of the urothelium. Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 2009, Volume: 61, Issue:1 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Paclitaxel; Palliative Care; Patient Selection; Retrospective Studies; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms; Urothelium	2009
Enzastaurin shows preclinical antitumor activity against human transitional cell carcinoma and enhances the activity of gemcitabine. Molecular cancer therapeutics, 2009, Volume: 8, Issue:7 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Deoxycytidine; Drug Synergism; Female; Gemcitabine; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Immunoenzyme Techniques; Indoles; Mice; Mice, Nude; Protein Kinase C; Protein Kinase C beta; Proto-Oncogene Proteins c-akt; Ribonucleotide Reductases	2009
Enterocolitis related to chemotherapy with gemcitabine and cisplatin in patient with transitional cell carcinoma of ureter. European journal of cancer care, 2009, Volume: 18, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Enterocolitis; Gemcitabine; Humans; Male; Tomography, X-Ray Computed; Ureteral Neoplasms	2009
Gemcitabine, paclitaxel, and cisplatin as combined adjuvant approach in transitional cell carcinoma of the urothelium. Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 2009, Volume: 61, Issue:3 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Middle Aged; Paclitaxel; Retrospective Studies; Ureteral Neoplasms; Urinary Bladder Neoplasms	2009
[Cerebral vasculitis associated with gemcitabine]. Der Urologe. Ausg. A, 2010, Volume: 49, Issue:2 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cerebral Cortex; Cisplatin; Cognition Disorders; Deoxycytidine; Epilepsy, Tonic-Clonic; Female; Gemcitabine; Humans; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Urinary Bladder Neoplasms; Vasculitis, Central Nervous System	2010
Efficacy of adjuvant gemcitabine-cisplatin chemotherapy: a comparative study between locally advanced transitional cell carcinoma of the bladder and upper urinary tract. Urologia internationalis, 2010, Volume: 85, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Chi-Square Distribution; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Republic of Korea; Retrospective Studies; Risk Assessment; Risk Factors; Survival Rate; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms; Urologic Neoplasms	2010
[Primary urothelial carcinoma with sarcomatous transformation of the prostate]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2010, Volume: 101, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Cystectomy; Deoxycytidine; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Invasiveness; Paclitaxel; Prostatectomy; Prostatic Neoplasms; Radiotherapy, Adjuvant; Sarcoma; Treatment Outcome; Urethral Neoplasms	2010
Combined chemotherapy with gemcitabine and cisplatin for metastatic urothelial carcinomas in patients 80 years of age and over. Anticancer research, 2010, Volume: 30, Issue:9 Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Retrospective Studies; Urinary Bladder Neoplasms	2010
A pilot study of gemcitabine in combination with oxaliplatin and vinorelbine in patients with metastatic bladder cancer. Anticancer research, 2010, Volume: 30, Issue:11 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Deoxycytidine; Gemcitabine; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Pilot Projects; Survival Rate; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine; Vinorelbine	2010
[Successful long-term management of hepatic and lymph nodes metastases of ureteral cancer by multimodal treatment including radiofrequency ablation]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2010, Volume: 101, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Catheter Ablation; Cisplatin; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Multiple Primary; Quality of Life; Treatment Outcome; Ureteral Neoplasms	2010
UBE2M-mediated p27(Kip1) degradation in gemcitabine cytotoxicity. Biochemical pharmacology, 2011, Jul-01, Volume: 82, Issue:1 Topics: Antimetabolites, Antineoplastic; Blotting, Western; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Survival; Chromones; Cyclin-Dependent Kinase Inhibitor p27; Deoxycytidine; Drug Screening Assays, Antitumor; Elafin; Formazans; Gemcitabine; Gene Expression Regulation; Gene Silencing; Humans; Morpholines; RNA, Small Interfering; Spectrometry, Mass, Electrospray Ionization; Tetrazolium Salts; Ubiquitins; Urinary Bladder Neoplasms	2011
Urothelial cancer cell response to combination therapy of gemcitabine and TRAIL. International journal of oncology, 2011, Volume: 39, Issue:1 Topics: Apoptosis; Carcinoma, Transitional Cell; Caspases; Cell Line, Tumor; Deoxycytidine; Drug Therapy, Combination; Gemcitabine; Humans; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand; Urinary Bladder Neoplasms	2011
Prognostic value of lymph-node dissection in patients undergoing radical cystectomy following previous oncological treatment for bladder cancer. Scandinavian journal of urology and nephrology, 2011, Volume: 45, Issue:6 Topics: Abdomen; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Deoxycytidine; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Salvage Therapy; Treatment Outcome; Urinary Bladder Neoplasms	2011
Relative efficacy of perioperative gemcitabine and cisplatin versus methotrexate, vinblastine, adriamycin, and cisplatin in the management of locally advanced urothelial carcinoma of the bladder. Urology, 2012, Volume: 79, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Deoxycytidine; Doxorubicin; Drug Evaluation; Female; Follow-Up Studies; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Proportional Hazards Models; Retrospective Studies; Urinary Bladder Neoplasms; Vinblastine	2012
Impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma treated by second-line chemotherapy with gemcitabine, etoposide and cisplatin. BJU international, 2012, Volume: 110, Issue:10 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; C-Reactive Protein; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Male; Middle Aged; Prognosis; Survival Rate; Urinary Bladder Neoplasms	2012
Effects of gemcitabine and gemcitabine in combination with carboplatin on five canine transitional cell carcinoma cell lines. American journal of veterinary research, 2012, Volume: 73, Issue:8 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Carboplatin; Carcinoma, Transitional Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Dog Diseases; Dogs; Drug Synergism; Drug Therapy, Combination; Gemcitabine	2012
Paclitaxel plus doxorubicin chemotherapy as second-line therapy in patients with advanced urothelial carcinoma pretreated with platinum plus gemcitabine chemotherapy. Onkologie, 2012, Volume: 35, Issue:10 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Male; Middle Aged; Paclitaxel; Platinum; Premedication; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms; Young Adult	2012
Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: a retrospective analysis from the University of Southern California. Urologic oncology, 2013, Volume: 31, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Cystectomy; Deoxycytidine; Doxorubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Proportional Hazards Models; Retrospective Studies; Urinary Bladder Neoplasms; Vinblastine	2013
Early detection and gemcitabine/cisplatin combination positively effect survival in sarcomatoid carcinoma of the urinary bladder. Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Early Diagnosis; Female; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Sarcoma; Survival Rate; Urinary Bladder; Urinary Bladder Neoplasms	2012
Antiangiogenic agents, chemotherapy, and the treatment of metastatic transitional cell carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Feb-20, Volume: 31, Issue:6 Topics: Acute Disease; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Indoles; Male; Neoplasm Metastasis; Neutropenia; Pancreatitis; Pyrroles; Sunitinib; Treatment Outcome; Ureteral Neoplasms; Urinary Bladder Neoplasms	2013
Combination of gemcitabine and carboplatin as first line treatment in elderly patients or those unfit for cisplatin-based chemotherapy with advanced transitional cell carcinoma of the urinary tract. Cancer chemotherapy and pharmacology, 2013, Volume: 71, Issue:4 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Urinary Bladder Neoplasms	2013
Intravesical therapy for superficial cancer: need for more options. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Aug-01, Volume: 20, Issue:15 Topics: Administration, Intravesical; Antimetabolites, Antineoplastic; BCG Vaccine; Carcinoma, Transitional Cell; Clinical Trials, Phase I as Topic; Deoxycytidine; Disease Progression; Gemcitabine; Humans; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms	2002
[Ureteroplasty using the appendix: apropos of a case]. Archivos espanoles de urologia, 2002, Volume: 55, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Appendix; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystectomy; Deoxycytidine; Gemcitabine; Humans; Laparotomy; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Nephrostomy, Percutaneous; Paclitaxel; Prostatectomy; Retroperitoneal Space; Transplantation, Autologous; Transplantation, Heterotopic; Ureter; Ureteral Neoplasms; Urinary Bladder Neoplasms	2002
[Successful salvage chemotherapy with gemcitabine, etoposide and cisplatin for metastatic ureteral cancer: a case report]. Hinyokika kiyo. Acta urologica Japonica, 2002, Volume: 48, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Etoposide; Gemcitabine; Humans; Lymphatic Metastasis; Male; Radiotherapy, Adjuvant; Remission Induction; Salvage Therapy; Treatment Outcome; Ureteral Neoplasms	2002
Extensive cutaneous metastasis of transitional cell carcinoma of the bladder. International journal of urology : official journal of the Japanese Urological Association, 2003, Volume: 10, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplatin; Carcinoma, Transitional Cell; Deoxycytidine; Fatal Outcome; Gemcitabine; Humans; Immunohistochemistry; Male; Neoplasm Staging; Severity of Illness Index; Skin Neoplasms; Treatment Refusal; Urinary Bladder Neoplasms	2003
Preclinical evaluation of a radiosensitizing effect of gemcitabine in p53 mutant and p53 wild type bladder cancer cells. Urology, 2003, Volume: 61, Issue:2 Topics: Animals; Apoptosis; Carcinoma, Transitional Cell; Cell Division; Cell Survival; Deoxycytidine; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Flow Cytometry; Gemcitabine; Genes, p53; Humans; In Situ Nick-End Labeling; Mutation; Radiation-Sensitizing Agents; Radiotherapy Dosage; Radiotherapy, Conformal; Tumor Cells, Cultured; Urinary Bladder Neoplasms	2003
Thrombotic microangiopathy and digital necrosis: two unrecognized toxicities of gemcitabine. Anti-cancer drugs, 2003, Volume: 14, Issue:10 Topics: Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Deoxycytidine; Fingers; Gangrene; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Iloprost; Male; Middle Aged; Pancreatic Neoplasms; Urinary Bladder Neoplasms; Vasodilator Agents	2003
Toxic epidermal necrolysis associated with gemcitabine therapy in a patient with metastatic transitional cell carcinoma of the bladder. Journal of chemotherapy (Florence, Italy), 2003, Volume: 15, Issue:5 Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Deoxycytidine; Fatal Outcome; Gemcitabine; Humans; Stevens-Johnson Syndrome; Urinary Bladder Neoplasms	2003
[Chemotherapy of bladder cancer. Systemic therapy with reduced toxicity]. Der Urologe. Ausg. A, 2003, Volume: 42, Issue:11 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Clinical Trials as Topic; Deoxycytidine; Feasibility Studies; Gemcitabine; Humans; Neoplasm Staging; Paclitaxel; Palliative Care; Urinary Bladder Neoplasms	2003
Gemcitabine-induced vasculitis in advanced transitional cell carcinoma of the bladder. Journal of cancer research and clinical oncology, 2004, Volume: 130, Issue:2 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cystectomy; Deoxycytidine; Gemcitabine; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms; Urinary Diversion; Vasculitis	2004
Gemcitabine plus carboplatin; and gemcitabine, docetaxel, and carboplatin combined chemotherapy regimens in patients with metastatic urothelial carcinoma previously treated with a platinum-based regimen: preliminary report. International journal of clinical oncology, 2004, Volume: 9, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis; Pilot Projects; Taxoids; Treatment Outcome; Ureteral Neoplasms; Urinary Bladder Neoplasms	2004
[Active chemotherapy with gemcitabine, carboplatin and docetaxel for three patients with MVAC-resistant liver metastasis of urothelial carcinoma]. Hinyokika kiyo. Acta urologica Japonica, 2004, Volume: 50, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Docetaxel; Doxorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Gemcitabine; Humans; Kidney Neoplasms; Liver Neoplasms; Male; Methotrexate; Middle Aged; Taxoids; Urinary Bladder Neoplasms; Vinblastine	2004
Our experience with 23 consecutive patients on gemcitabine/carboplatin chemotherapy for treatment of metastasized transitional cell carcinoma of the urothelium. International journal of urology : official journal of the Japanese Urological Association, 2004, Volume: 11, Issue:7 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Urologic Neoplasms; Urothelium	2004
Gemcitabine-associated scleroderma-like changes of the lower extremities. Journal of the American Academy of Dermatology, 2004, Volume: 51, Issue:2 Suppl Topics: Acetaminophen; Amitriptyline; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Neoplasms; Carcinoma, Transitional Cell; Cisplatin; Clonazepam; Deoxycytidine; Dermis; Doxorubicin; Edema; Gemcitabine; Humans; Infusions, Intravenous; Leg; Lung Neoplasms; Male; Methotrexate; Middle Aged; Morphine; Scleroderma, Diffuse; Vinblastine	2004
Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and gemcitabine in a human bladder cancer KoTCC-1 model. The Journal of urology, 2004, Volume: 172, Issue:4 Pt 1 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cell Division; Cell Line, Tumor; Cell Survival; Cyclohexanes; Deoxycytidine; Drug Synergism; Female; Gemcitabine; Humans; Lymphatic Metastasis; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Sesquiterpenes; Tumor Cells, Cultured; Urinary Bladder Neoplasms	2004
Synchronous solitary metastasis of transitional cell carcinoma of the bladder to the testis. Urology, 2004, Volume: 64, Issue:4 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Cystitis; Deoxycytidine; Gemcitabine; Hematuria; Humans; Incidental Findings; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Orchiectomy; Positron-Emission Tomography; Prostatectomy; Prostatic Neoplasms; Radiation Injuries; Testicular Neoplasms; Transurethral Resection of Prostate; Ultrasonography; Urinary Bladder Neoplasms; Urinary Diversion	2004
Antineoplastic effect of gemcitabine in an animal model of superficial bladder cancer. Urology, 2004, Volume: 64, Issue:4 Topics: Administration, Intravesical; Animals; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Cystitis; Deoxycytidine; Drug Screening Assays, Antitumor; Female; Fibrosis; Gemcitabine; Hyperplasia; Injections, Intraperitoneal; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Organ Size; Single-Blind Method; Urinary Bladder Neoplasms; Urothelium	2004
[Initial results of intra-arterial chemotherapy for poorly differentiated bladder transitional cell carcinoma]. Ai zheng = Aizheng = Chinese journal of cancer, 2004, Volume: 23, Issue:11 Suppl Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Deoxycytidine; Drug Administration Schedule; Female; Follow-Up Studies; Gemcitabine; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Urinary Bladder Neoplasms	2004
FOLFOX-4 in pre-treated patients with advanced transitional cell carcinoma of the bladder. Japanese journal of clinical oncology, 2004, Volume: 34, Issue:12 Topics: Aged; Aged, 80 and over; Agranulocytosis; Anemia; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoembryonic Antigen; Carcinoma, Transitional Cell; Deoxycytidine; Drug Administration Schedule; Energy Intake; Female; Fluorouracil; Gemcitabine; Humans; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Stomatitis; Taxoids; Tissue Polypeptide Antigen; Urinary Bladder Neoplasms	2004
Successful treatment of chemo-refractory pulmonary metastases of renal pelvic cancer by second-line chemotherapy including gemcitabine followed by salvage surgery. International journal of urology : official journal of the Japanese Urological Association, 2005, Volume: 12, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Drug Resistance, Neoplasm; Etoposide; Female; Gemcitabine; Humans; Kidney Neoplasms; Kidney Pelvis; Lung Neoplasms; Middle Aged; Salvage Therapy	2005
Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: an in vitro study. The Journal of urology, 2005, Volume: 173, Issue:4 Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coloring Agents; Combined Modality Therapy; Deoxycytidine; Epirubicin; Gemcitabine; Humans; Hyperthermia, Induced; Indolequinones; Mitomycin; Tetrazolium Salts; Thiazoles; Urinary Bladder Neoplasms	2005
Vascular endothelial growth factor antisense pretreatment of bladder cancer cells significantly enhances the cytotoxicity of mitomycin C, gemcitabine and Cisplatin. The Journal of urology, 2005, Volume: 174, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Transitional Cell; Cell Line, Tumor; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Mitomycin; Oligonucleotides, Antisense; Urinary Bladder Neoplasms; Vascular Endothelial Growth Factor A	2005
Inhibition of tumor implantation by intravesical gemcitabine in a murine model of superficial bladder cancer. The Journal of urology, 2005, Volume: 174, Issue:3 Topics: Administration, Intravesical; Animals; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Cell Division; Cell Line, Tumor; Deoxycytidine; Gemcitabine; Mice; Neoplasm Seeding; Neoplasm Transplantation; Tumor Cells, Cultured; Urinary Bladder; Urinary Bladder Neoplasms	2005
Double diagnosis in cancer patients and cutaneous reaction related to gemcitabine: CASE 3. Photo therapy recall with gemcitabine following ultraviolet B treatment. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Oct-01, Volume: 23, Issue:28 Topics: Adrenal Cortex Hormones; Aged; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Deoxycytidine; Gemcitabine; Humans; Inflammation; Keratinocytes; Male; Photosensitivity Disorders; Phototherapy; Ultraviolet Rays; Urinary Bladder Neoplasms	2005
Gemcitabine in intravesical treatment of Ta-T1 transitional cell carcinoma of the bladder. Urology, 2005, Volume: 66, Issue:5 Topics: Administration, Intravesical; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Deoxycytidine; Gemcitabine; Humans; Neoplasm Staging; Urinary Bladder Neoplasms	2005
What's happening in PHARMAC--where do all the submissions go? On the trail of gemcitabine. The New Zealand medical journal, 2005, Nov-11, Volume: 118, Issue:1225 Topics: Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Deoxycytidine; Drug Approval; Gemcitabine; Humans; National Health Programs; New Zealand; Urinary Bladder Neoplasms	2005
PHARMAC's response on gemcitabine and transparency. The New Zealand medical journal, 2005, Nov-11, Volume: 118, Issue:1225 Topics: Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Deoxycytidine; Drug Approval; Gemcitabine; Humans; National Health Programs; New Zealand; Urinary Bladder Neoplasms	2005
Aggressive multimodality treatment in transitional cell carcinoma of the parafallopian tube: report of 2 cases and review of the literature. Gynecologic oncology, 2006, Volume: 102, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Deoxycytidine; Fallopian Tube Neoplasms; Female; Gemcitabine; Humans; Middle Aged; Paclitaxel	2006
Pelvic chemoradiotherapy after chemotherapy for metastatic bladder cancer. The Canadian journal of urology, 2006, Volume: 13, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Combined Modality Therapy; Deoxycytidine; Disease Progression; Disease-Free Survival; Female; Gemcitabine; Humans; Male; Middle Aged; Pelvic Neoplasms; Prognosis; Radiotherapy Dosage; Urinary Bladder Neoplasms	2006
Long-term survival under maintenance gemcitabine chemotherapy for metastatic transitional cell carcinoma. International journal of urology : official journal of the Japanese Urological Association, 2006, Volume: 13, Issue:7 Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Lung Neoplasms; Retroperitoneal Neoplasms; Ribonucleotide Reductases; Survival Rate; Time Factors; Urinary Bladder Neoplasms	2006
Haematological toxicity in patients treated with cisplatin and gemcitabine for bladder cancer: the Weston Park Hospital, Sheffield, experience. Clinical oncology (Royal College of Radiologists (Great Britain)), 2006, Volume: 18, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Thrombocytopenia; Treatment Outcome; Urinary Bladder Neoplasms	2006
Feasiblity study of gemcitabine and cisplatin administered every two weeks in patients with advanced urothelial tumors and impaired renal function. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2006, Volume: 8, Issue:10 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Creatinine; Deoxycytidine; Feasibility Studies; Female; Gemcitabine; Humans; Karnofsky Performance Status; Male; Middle Aged; Neoplasm Metastasis; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms	2006
Gemcitabine-induced apoptosis in 5637 cell line: an in-vitro model for high-risk superficial bladder cancer. Anti-cancer drugs, 2007, Volume: 18, Issue:2 Topics: Antimetabolites, Antineoplastic; Apoptosis; bcl-X Protein; Carcinoma, Transitional Cell; Caspases; Cell Line, Tumor; Cell Survival; Deoxycytidine; DNA Fragmentation; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Fluorescent Antibody Technique; Gemcitabine; Humans; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; Urinary Bladder Neoplasms	2007
Long-term survival after gemcitabine and cisplatin in patients with locally advanced transitional cell carcinoma of the bladder: focus on supplementary treatment strategies. European urology, 2007, Volume: 52, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chi-Square Distribution; Cisplatin; Combined Modality Therapy; Deoxycytidine; Disease Progression; Female; Gemcitabine; Humans; Male; Middle Aged; Proportional Hazards Models; Survival Rate; Treatment Outcome; Urinary Bladder Neoplasms	2007
Editorial comment on: Long-term survival after gemcitabine and cisplatin in patients with locally advanced transitional cell carcinoma of the bladder: focus on supplementary treatment strategies. European urology, 2007, Volume: 52, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Deoxycytidine; Disease Progression; Female; Gemcitabine; Humans; Male; Middle Aged; Survival Rate; Treatment Outcome; Urinary Bladder Neoplasms	2007
Metastatic urothelial carcinoma of upper urinary tract. American journal of hematology, 2007, Volume: 82, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Deoxycytidine; Fatal Outcome; Gemcitabine; Hematologic Diseases; Humans; Hypercalcemia; Kidney Neoplasms; Male; Middle Aged; Ureteral Neoplasms	2007
Gemcitabine and cisplatin in locally advanced and metastatic bladder cancer; 3- or 4-week schedule? Acta oncologica (Stockholm, Sweden), 2008, Volume: 47, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Disease Progression; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms	2008
Progression of disease despite good endoscopic local control of upper tract urothelial carcinoma. Urology, 2007, Volume: 70, Issue:3 Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Papillary; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Deoxycytidine; Disease Progression; Docetaxel; Electrocoagulation; Gemcitabine; Humans; Kidney Neoplasms; Kidney Pelvis; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Nephrectomy; Paclitaxel; Taxoids; Ureteroscopy	2007
Tumor lysis syndrome after treatment with gemcitabine for metastatic transitional cell carcinoma. Medical oncology (Northwood, London, England), 2007, Volume: 24, Issue:4 Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Deoxycytidine; Fatal Outcome; Female; Gemcitabine; Humans; Kidney Neoplasms; Tumor Lysis Syndrome	2007
Methotrexate, vinblastine, doxorubicin and cisplatin combination regimen as salvage chemotherapy for patients with advanced or metastatic transitional cell carcinoma after failure of gemcitabine and cisplatin chemotherapy. British journal of cancer, 2008, Jan-15, Volume: 98, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Kidney Neoplasms; Male; Methotrexate; Middle Aged; Salvage Therapy; Survival Rate; Treatment Failure; Treatment Outcome; Vinblastine	2008
Ureterovesical malignancy following renal transplantation: a case report. Transplantation proceedings, 2007, Volume: 39, Issue:10 Topics: Adult; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Deoxycytidine; Gemcitabine; Humans; Incidence; Kidney Transplantation; Male; Peritoneal Dialysis, Continuous Ambulatory; Radiography; Time Factors; Ureteral Neoplasms; Urinary Bladder Neoplasms	2007
[Elevation of CA 19.9 in urothelial bladder cancer]. Medicina clinica, 2008, Mar-08, Volume: 130, Issue:8 Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; CA-19-9 Antigen; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Time Factors; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2008
Biweekly carboplatin/gemcitabine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: report of efficacy, quality of life and geriatric assessment. Oncology, 2007, Volume: 73, Issue:5-6 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Creatinine; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Middle Aged; Patient Selection; Quality of Life; Survival Analysis; Treatment Outcome; Urologic Neoplasms	2007
Gemcitabine and cisplatin for advanced, metastatic bladder cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Feb-15, Volume: 19, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Methotrexate; Neoplasm Metastasis; Urinary Bladder Neoplasms; Vinblastine	2001
Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: effective treatment of patients with poor prognostic features. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:7 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Pilot Projects; Prognosis; Treatment Outcome; Urologic Neoplasms; Urothelium	2001